{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T18:01:57Z","timestamp":1789754517593,"version":"4.0.1"},"reference-count":495,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["IG grant 2024 ID 30421"],"award-info":[{"award-number":["IG grant 2024 ID 30421"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["IG grant 2024 ID 30421"],"award-info":[{"award-number":["IG grant 2024 ID 30421"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell'Istruzione, dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["PRIN 2022 PNRR Codice progetto \u201cP20224JCNN\u201d"],"award-info":[{"award-number":["PRIN 2022 PNRR Codice progetto \u201cP20224JCNN\u201d"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"DOI":"10.1038\/s41392-026-02940-w","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T15:39:35Z","timestamp":1789745975000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Chromosomal instability in cancer: sources, consequences and new therapeutic opportunities"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8649-5603","authenticated-orcid":false,"given":"Angela Flavia","family":"Serpico","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7131-5742","authenticated-orcid":false,"given":"Domenico","family":"Grieco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,18]]},"reference":[{"key":"2940_CR1","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41580-021-00404-3","volume":"23","author":"HK Matthews","year":"2022","unstructured":"Matthews, H. K., Bertoli, C. & de Bruin, R. A. M. Cell cycle control in cancer. Nat. Rev. Mol. Cell Biol. 23, 74\u201388 (2022).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2940_CR2","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1101\/gad.314351.118","volume":"32","author":"MS Levine","year":"2018","unstructured":"Levine, M. S. & Holland, A. J. The impact of mitotic errors on cell proliferation and tumorigenesis. Genes Dev. 32, 620\u2013638 (2018).","journal-title":"Genes Dev."},{"key":"2940_CR3","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.molcel.2016.05.021","volume":"62","author":"EM Kass","year":"2016","unstructured":"Kass, E. M., Moynahan, M. E. & Jasin, M. When genome maintenance goes badly awry. Mol. Cell. 62, 777\u2013787 (2016).","journal-title":"Mol. Cell."},{"key":"2940_CR4","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41576-024-00761-7","volume":"26","author":"X Chen","year":"2025","unstructured":"Chen, X. et al. Chromosomal instability as a driver of cancer progression. Nat. Rev. Genet. 26, 31\u201346 (2025).","journal-title":"Nat. Rev. Genet."},{"key":"2940_CR5","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1038\/s41586-022-04789-9","volume":"606","author":"RM Drews","year":"2022","unstructured":"Drews, R. M. et al. A pan-cancer compendium of chromosomal instability. Nature 606, 976\u2013983 (2022).","journal-title":"Nature"},{"key":"2940_CR6","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1038\/s41416-019-0723-z","volume":"122","author":"E Rassy","year":"2020","unstructured":"Rassy, E., Assi, T. & Pavlidis, N. Exploring the biological hallmarks of cancer of unknown primary: where do we stand today? Br. J. Cancer 122, 1124\u20131132 (2020).","journal-title":"Br. J. Cancer"},{"key":"2940_CR7","doi-asserted-by":"publisher","first-page":"6401","DOI":"10.1158\/0008-5472.CAN-13-0749","volume":"73","author":"JM Sheltzer","year":"2013","unstructured":"Sheltzer, J. M. A transcriptional and metabolic signature of primary aneuploidy is present in chromosomally unstable cancer cells and informs clinical prognosis. Cancer Res. 73, 6401\u20136412 (2013).","journal-title":"Cancer Res."},{"key":"2940_CR8","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41576-019-0171-x","volume":"21","author":"U Ben-David","year":"2020","unstructured":"Ben-David, U. & Amon, A. Context is everything: aneuploidy in cancer. Nat. Rev. Genet. 21, 44\u201362 (2020).","journal-title":"Nat. Rev. Genet."},{"key":"2940_CR9","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.omto.2020.05.010","volume":"17","author":"F Kou","year":"2020","unstructured":"Kou, F., Wu, L., Ren, X. & Yang, L. Chromosome abnormalities: new insights into their clinical significance in cancer. Mol. Ther. Oncolytics 17, 562\u2013570 (2020).","journal-title":"Mol. Ther. Oncolytics"},{"key":"2940_CR10","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.05068","volume":"4","author":"JM Nicholson","year":"2015","unstructured":"Nicholson, J. M. et al. Chromosome mis-segregation and cytokinesis failure in trisomic human cells. Elife 4, e05068 (2015).","journal-title":"Elife"},{"key":"2940_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10754","volume":"7","author":"V Passerini","year":"2016","unstructured":"Passerini, V. et al. The presence of extra chromosomes leads to genomic instability. Nat. Commun. 7, 10754 (2016).","journal-title":"Nat. Commun."},{"key":"2940_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41389-018-0072-4","volume":"7","author":"Q He","year":"2018","unstructured":"He, Q. et al. Chromosomal instability-induced senescence potentiates cell non-autonomous tumourigenic effects. Oncogenesis 7, 62 (2018).","journal-title":"Oncogenesis"},{"key":"2940_CR13","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41568-020-00321-1","volume":"21","author":"A Vasudevan","year":"2021","unstructured":"Vasudevan, A. et al. Aneuploidy as a promoter and suppressor of malignant growth. Nat. Rev. Cancer 21, 89\u2013103 (2021).","journal-title":"Nat. Rev. Cancer"},{"key":"2940_CR14","doi-asserted-by":"publisher","first-page":"19108","DOI":"10.1073\/pnas.0904343106","volume":"106","author":"A Janssen","year":"2009","unstructured":"Janssen, A., Kops, G. J. P. L. & Medema, R. H. Elevating the frequency of chromosome mis-segregation as a strategy to kill tumor cells. Proc. Natl. Acad. Sci. USA 106, 19108\u201319113 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2940_CR15","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41392-024-01767-7","volume":"9","author":"R Hosea","year":"2024","unstructured":"Hosea, R., Hillary, S., Naqvi, S., Wu, S. & Kasim, V. The two sides of chromosomal instability: drivers and brakes in cancer. Sig. Transduct. Target. Ther. 9, 75 (2024).","journal-title":"Sig. Transduct. Target. Ther."},{"key":"2940_CR16","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.gde.2007.02.011","volume":"17","author":"NJ Ganem","year":"2007","unstructured":"Ganem, N. J., Storchova, Z. & Pellman, D. Tetraploidy, aneuploidy and cancer. Curr. Opin. Genet. Dev. 17, 157\u2013162 (2007).","journal-title":"Curr. Opin. Genet. Dev."},{"key":"2940_CR17","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41586-019-1913-9","volume":"578","author":"Y Li","year":"2020","unstructured":"Li, Y. et al. Patterns of somatic structural variation in human cancer genomes. Nature 578, 112\u2013121 (2020).","journal-title":"Nature"},{"key":"2940_CR18","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/nature10802","volume":"482","author":"K Crasta","year":"2012","unstructured":"Crasta, K. et al. DNA breaks and chromosome pulverization from errors in mitosis. Nature 482, 53\u201358 (2012).","journal-title":"Nature"},{"key":"2940_CR19","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/nature11935","volume":"494","author":"RA Burrell","year":"2013","unstructured":"Burrell, R. A. et al. Replication stress links structural and numerical cancer chromosomal instability. Nature 494, 492\u2013496 (2013).","journal-title":"Nature"},{"key":"2940_CR20","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1158\/2159-8290.CD-14-0403","volume":"4","author":"SF Bakhoum","year":"2014","unstructured":"Bakhoum, S. F., Kabeche, L., Murnane, J. P., Zaki, B. I. & Compton, D. A. DNA-damage response during mitosis induces whole-chromosome mis-segregation. Cancer Discov. 4, 1281\u20131289 (2014).","journal-title":"Cancer Discov."},{"key":"2940_CR21","doi-asserted-by":"publisher","first-page":"3139","DOI":"10.1038\/s41388-024-03163-5","volume":"43","author":"R Devillers","year":"2024","unstructured":"Devillers, R., Dos Santos, A., Destombes, Q., Laplante, M. & Elowe, S. Recent insights into the causes and consequences of chromosome mis-segregation. Oncogene 43, 3139\u20133150 (2024).","journal-title":"Oncogene"},{"key":"2940_CR22","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/s41576-023-00663-0","volume":"25","author":"K Krupina","year":"2024","unstructured":"Krupina, K., Goginashvili, A. & Cleveland, D. W. Scrambling the genome in cancer: causes and consequences of complex chromosome rearrangements. Nat. Rev. Genet. 25, 196\u2013210 (2024).","journal-title":"Nat. Rev. Genet."},{"key":"2940_CR23","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nrm3916","volume":"16","author":"KM Godek","year":"2015","unstructured":"Godek, K. M., Kabeche, L. & Compton, D. A. Regulation of kinetochore-microtubule attachments through homeostatic control during mitosis. Nat. Rev. Mol. Cell Biol. 16, 57\u201364 (2015).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2940_CR24","doi-asserted-by":"publisher","unstructured":"Jaggi, K. E., Hoyt, S. J., O\u2019Neill, R. J. & Sullivan, B. A. A genomic and epigenomic view of human centromeres. Nat. Rev. Genet. https:\/\/doi.org\/10.1038\/s41576-025-00923-1 (2026).","DOI":"10.1038\/s41576-025-00923-1"},{"key":"2940_CR25","doi-asserted-by":"publisher","first-page":"R449","DOI":"10.1016\/S0960-9822(03)00369-5","volume":"13","author":"S Biggins","year":"2003","unstructured":"Biggins, S. & Walczak, C. E. Captivating capture: how microtubules attach to kinetochores. Curr. Biol. 13, R449\u2013R460 (2003).","journal-title":"Curr. Biol."},{"key":"2940_CR26","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1007\/s00018-020-03472-4","volume":"77","author":"M Hara","year":"2020","unstructured":"Hara, M. & Fukagawa, T. Dynamics of kinetochore structure and its regulations during mitotic progression. Cell. Mol. Life Sci. 77, 2981\u20132995 (2020).","journal-title":"Cell. Mol. Life Sci."},{"key":"2940_CR27","doi-asserted-by":"publisher","first-page":"17974","DOI":"10.1073\/pnas.1109720108","volume":"108","author":"SL Thompson","year":"2011","unstructured":"Thompson, S. L. & Compton, D. A. Chromosome missegregation in human cells arises through specific types of kinetochore-microtubule attachment errors. Proc. Natl. Acad. Sci. USA 108, 17974\u201317978 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2940_CR28","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.tcb.2011.01.003","volume":"21","author":"J Gregan","year":"2011","unstructured":"Gregan, J., Polakova, S., Zhang, L., Toli\u0107-N\u00f8rrelykke, I. M. & Cimini, D. Merotelic kinetochore attachment: causes and effects. Trends Cell Biol. 21, 374\u2013381 (2011).","journal-title":"Trends Cell Biol."},{"key":"2940_CR29","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/nrm3494","volume":"14","author":"EA Foley","year":"2013","unstructured":"Foley, E. A. & Kapoor, T. M. Microtubule attachment and spindle assembly checkpoint signalling at the kinetochore. Nat. Rev. Mol. Cell Biol. 14, 25\u201337 (2013).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2940_CR30","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ceb.2009.01.004","volume":"21","author":"AE Kelly","year":"2009","unstructured":"Kelly, A. E. & Funabiki, H. Correcting aberrant kinetochore microtubule attachments: an Aurora B-centric view. Curr. Opin. Cell Biol. 21, 51\u201358 (2009).","journal-title":"Curr. Opin. Cell Biol."},{"key":"2940_CR31","doi-asserted-by":"publisher","first-page":"102462","DOI":"10.1016\/j.ceb.2024.102462","volume":"92","author":"S Matsui","year":"2025","unstructured":"Matsui, S., Nozawa, R. S. & Hirota, T. Organization of the chromosomal passenger complex clusters at inner centromeres in mitosis. Curr. Opin. Cell Biol. 92, 102462 (2025).","journal-title":"Curr. Opin. Cell Biol."},{"key":"2940_CR32","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cub.2004.01.055","volume":"14","author":"W Lan","year":"2004","unstructured":"Lan, W. et al. Aurora B phosphorylates centromeric MCAK and regulates its localization and microtubule depolymerization activity. Curr. Biol. 14, 273\u2013286 (2004).","journal-title":"Curr. Biol."},{"key":"2940_CR33","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1083\/jcb.201302123","volume":"202","author":"R Uehara","year":"2013","unstructured":"Uehara, R. et al. Aurora B and Kif2A control microtubule length for assembly of a functional central spindle during anaphase. J. Cell Biol. 202, 623\u2013636 (2013).","journal-title":"J. Cell Biol."},{"key":"2940_CR34","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1083\/jcb.201109001","volume":"196","author":"YW Chan","year":"2012","unstructured":"Chan, Y. W., Jeyaprakash, A. A., Nigg, E. A. & Santamaria, A. Aurora B controls kinetochore\u2013microtubule attachments by inhibiting Ska complex\u2013KMN network interaction. J. Cell Biol. 196, 563\u2013571 (2012).","journal-title":"J. Cell Biol."},{"key":"2940_CR35","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/ncb1809","volume":"11","author":"SF Bakhoum","year":"2009","unstructured":"Bakhoum, S. F., Thompson, S. L., Manning, A. L. & Compton, D. A. Genome stability is ensured by temporal control of kinetochore\u2013microtubule dynamics. Nat. Cell Biol. 11, 27\u201335 (2009).","journal-title":"Nat. Cell Biol."},{"key":"2940_CR36","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1016\/j.cub.2009.09.055","volume":"19","author":"SF Bakhoum","year":"2009","unstructured":"Bakhoum, S. F., Genovese, G. & Compton, D. A. Deviant kinetochore microtubule dynamics underlie chromosomal instability. Curr. Biol. 19, 1937\u20131942 (2009).","journal-title":"Curr. Biol."},{"key":"2940_CR37","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1016\/j.cub.2006.07.022","volume":"16","author":"D Cimini","year":"2006","unstructured":"Cimini, D., Wan, X. H., Hirel, C. B. & Salmon, E. D. Aurora kinase promotes turnover of kinetochore microtubules to reduce chromosome segregation errors. Curr. Biol. 16, 1711\u20131718 (2006).","journal-title":"Curr. Biol."},{"key":"2940_CR38","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1091\/mbc.e03-08-0581","volume":"15","author":"SL Kline-Smith","year":"2004","unstructured":"Kline-Smith, S. L., Khodjakov, A., Hergert, P. & Walczak, C. E. Depletion of centromeric MCAK leads to chromosome congression and segregation defects due to improper kinetochore attachments. Mol. Biol. Cell 15, 1145\u20131159 (2004).","journal-title":"Mol. Biol. Cell"},{"key":"2940_CR39","doi-asserted-by":"publisher","first-page":"16719","DOI":"10.1073\/pnas.0803504105","volume":"105","author":"E Diaz-Rodriguez","year":"2008","unstructured":"Diaz-Rodriguez, E., Sotillo, R., Scvartzman, J. M. & Benezra, R. Hec1 overexpression hyperactivates the mitotic checkpoint and induces tumor formation in vivo. Proc. Natl. Acad. Sci. USA 105, 16719\u201316724 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2940_CR40","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.cell.2007.11.046","volume":"132","author":"N Jelluma","year":"2008","unstructured":"Jelluma, N. et al. Mps1 phosphorylates Borealin to control Aurora B activity and chromosome alignment. Cell 132, 233\u2013246 (2008).","journal-title":"Cell"},{"key":"2940_CR41","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1038\/ng1449","volume":"36","author":"S Hanks","year":"2004","unstructured":"Hanks, S. et al. Constitutional aneuploidy and cancer predisposition caused by biallelic mutations in BUB1B. Nat. Genet. 36, 1159\u20131161 (2004).","journal-title":"Nat. Genet."},{"key":"2940_CR42","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ccr.2006.10.019","volume":"11","author":"R Sotillo","year":"2007","unstructured":"Sotillo, R. et al. Mad2 overexpression promotes aneuploidy and tumorigenesis in mice. Cancer Cell 11, 9\u201323 (2007).","journal-title":"Cancer Cell"},{"key":"2940_CR43","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1016\/j.cub.2009.07.059","volume":"19","author":"S Maffini","year":"2009","unstructured":"Maffini, S. et al. Motor-independent targeting of CLASPs to kinetochores by CENP-E promotes microtubule turnover and poleward flux. Curr. Biol. 19, 1566\u20131572 (2009).","journal-title":"Curr. Biol."},{"key":"2940_CR44","doi-asserted-by":"publisher","first-page":"4526","DOI":"10.1091\/mbc.e06-07-0579","volume":"17","author":"AL Pereira","year":"2006","unstructured":"Pereira, A. L. et al. Mammalian CLASP1 and CLASP2 cooperate to ensure mitotic fidelity by regulating spindle and kinetochore function. Mol. Biol. Cell 17, 4526\u20134542 (2006).","journal-title":"Mol. Biol. Cell"},{"key":"2940_CR45","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1083\/jcb.200307070","volume":"163","author":"RA Green","year":"2003","unstructured":"Green, R. A. & Kaplan, K. B. Chromosome instability in colorectal tumor cells is associated with defects in microtubule plus-end attachments caused by dominant mutation in APC. J. Cell Biol. 163, 949\u2013961 (2003).","journal-title":"J. Cell Biol."},{"key":"2940_CR46","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.1038\/sj.emboj.7601168","volume":"25","author":"VM Draviam","year":"2006","unstructured":"Draviam, V. M., Shapiro, I., Aldridge, B. & Sorger, P. K. Misorientation and reduced stretching of aligned sister kinetochores promote chromosome missegregation in EB1- or APC-depleted cells. EMBO J. 25, 2814\u20132827 (2006).","journal-title":"EMBO J."},{"key":"2940_CR47","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1126\/science.1145720","volume":"318","author":"LD Wood","year":"2007","unstructured":"Wood, L. D. et al. The genomic landscapes of human breast and colorectal cancers. Science 318, 1108\u20131113 (2007).","journal-title":"Science"},{"key":"2940_CR48","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nature05610","volume":"446","author":"C Greenman","year":"2007","unstructured":"Greenman, C. et al. Patterns of somatic mutation in human cancer genomes. Nature 446, 153\u2013158 (2007).","journal-title":"Nature"},{"key":"2940_CR49","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3389\/fendo.2015.00060","volume":"6","author":"S Nath","year":"2015","unstructured":"Nath, S., Ghatak, D., Das, P. & Roychoudhury, S. Transcriptional control of mitosis: deregulation and cancer. Front. Endocrinol. 6, 60 (2015).","journal-title":"Front. Endocrinol."},{"key":"2940_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06545-y","volume":"9","author":"V Barra","year":"2018","unstructured":"Barra, V. & Fachinetti, D. The dark side of centromeres: types, causes and consequences of structural abnormalities implicating centromeric DNA. Nat. Commun. 9, 4340 (2018).","journal-title":"Nat. Commun."},{"key":"2940_CR51","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.202007195","volume":"220","author":"RL Shrestha","year":"2021","unstructured":"Shrestha, R. L. et al. CENP-A overexpression promotes aneuploidy with karyotypic heterogeneity. J. Cell Biol. 220, e202007195 (2021).","journal-title":"J. Cell Biol."},{"key":"2940_CR52","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1002\/ijc.30133","volume":"139","author":"X Sun","year":"2016","unstructured":"Sun, X. et al. Elevated expression of the centromere protein-A(CENP-A)-encoding gene as a prognostic and predictive biomarker in human cancers. Int. J. Cancer 139, 899\u2013907 (2016).","journal-title":"Int. J. Cancer"},{"key":"2940_CR53","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s10577-025-09779-x","volume":"33","author":"A Enriquez","year":"2025","unstructured":"Enriquez, A. & Nechemia-Arbely, Y. The dynamic centromere. Chromosome Res. 33, 22 (2025).","journal-title":"Chromosome Res."},{"key":"2940_CR54","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/s42003-021-01941-5","volume":"4","author":"D Jeffery","year":"2021","unstructured":"Jeffery, D. et al. CENP-A overexpression promotes distinct fates in human cells, depending on p53 status. Commun. Biol. 4, 417 (2021).","journal-title":"Commun. Biol."},{"key":"2940_CR55","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1016\/j.molcel.2022.02.032","volume":"82","author":"F Chardon","year":"2022","unstructured":"Chardon, F. et al. CENP-B-mediated DNA loops regulate activity and stability of human centromeres. Mol. Cell 82, 1751\u20131767.e8 (2022).","journal-title":"Mol. Cell"},{"key":"2940_CR56","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.devcel.2015.03.020","volume":"33","author":"D Fachinetti","year":"2015","unstructured":"Fachinetti, D. et al. DNA sequence-specific binding of CENP-B enhances the fidelity of human centromere function. Dev. Cell 33, 314\u2013327 (2015).","journal-title":"Dev. Cell"},{"key":"2940_CR57","doi-asserted-by":"publisher","first-page":"R1002","DOI":"10.1016\/j.cub.2015.08.051","volume":"25","author":"A Musacchio","year":"2015","unstructured":"Musacchio, A. The molecular biology of spindle assembly checkpoint signaling dynamics. Curr. Biol. 25, R1002\u2013R1018 (2015).","journal-title":"Curr. Biol."},{"key":"2940_CR58","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/s41580-023-00593-z","volume":"24","author":"AD McAinsh","year":"2023","unstructured":"McAinsh, A. D. & Kops, G. J. Principles and dynamics of spindle assembly checkpoint signalling. Nat. Rev. Mol. Cell Biol. 24, 543\u2013559 (2023).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2940_CR59","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1016\/j.yexcr.2012.04.008","volume":"318","author":"NT Umbreit","year":"2012","unstructured":"Umbreit, N. T. & Davis, T. N. Mitosis puts sisters in a strained relationship: force generation at the kinetochore. Exp. Cell Res. 318, 1361\u20131366 (2012).","journal-title":"Exp. Cell Res."},{"key":"2940_CR60","first-page":"32","volume":"1786","author":"D Cimini","year":"2008","unstructured":"Cimini, D. Merotelic kinetochore orientation, aneuploidy, and cancer. Biochim. Biophys. Acta 1786, 32\u201340 (2008).","journal-title":"Biochim. Biophys. Acta"},{"key":"2940_CR61","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1083\/jcb.200102093","volume":"154","author":"V Sudakin","year":"2001","unstructured":"Sudakin, V., Chan, G. K. & Yen, T. J. Checkpoint inhibition of the APC\/C in HeLa cells is mediated by a complex of BUBR1, BUB3, CDC20, and MAD2. J. Cell Biol. 154, 925\u2013936 (2001).","journal-title":"J. Cell Biol."},{"key":"2940_CR62","doi-asserted-by":"publisher","first-page":"jcs191353","DOI":"10.1242\/jcs.191353","volume":"131","author":"T Courtheoux","year":"2018","unstructured":"Courtheoux, T. et al. Aurora A kinase activity is required to maintain an active spindle assembly checkpoint during prometaphase. J. Cell Sci. 131, jcs191353 (2018).","journal-title":"J. Cell Sci."},{"key":"2940_CR63","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.cub.2021.10.049","volume":"32","author":"B Roy","year":"2022","unstructured":"Roy, B., Han, S. J. Y., Fontan, A. N., Jema, S. & Joglekar, A. P. Aurora B phosphorylates Bub1 to promote spindle assembly checkpoint signaling. Curr. Biol. 32, 237\u2013247.e6 (2022).","journal-title":"Curr. Biol."},{"key":"2940_CR64","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1242\/bio.014969","volume":"5","author":"A O\u2019Connor","year":"2015","unstructured":"O\u2019Connor, A. et al. Requirement for PLK1 kinase activity in the maintenance of a robust spindle assembly checkpoint. Biol. Open. 5, 11\u201319 (2015).","journal-title":"Biol. Open."},{"key":"2940_CR65","doi-asserted-by":"publisher","first-page":"180109","DOI":"10.1098\/rsob.180109","volume":"8","author":"ST Pachis","year":"2018","unstructured":"Pachis, S. T. & Kops, G. J. P. L. Leader of the SAC: molecular mechanisms of Mps1\/TTK regulation in mitosis. Open Biol. 8, 180109 (2018).","journal-title":"Open Biol."},{"key":"2940_CR66","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1101\/gad.267603","volume":"17","author":"V D\u2019Angiolella","year":"2003","unstructured":"D\u2019Angiolella, V., Mari, C., Nocera, D., Rametti, L. & Grieco, D. The spindle checkpoint requires cyclin-dependent kinase activity. Genes Dev. 17, 2520\u20132525 (2003).","journal-title":"Genes Dev."},{"key":"2940_CR67","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.21185.1","volume":"9","author":"AF Serpico","year":"2020","unstructured":"Serpico, A. F. & Grieco, D. Recent advances in understanding the role of Cdk1 in the spindle assembly checkpoint. F1000Res 9, F1000 (2020).","journal-title":"F1000Res"},{"key":"2940_CR68","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s00018-023-04727-6","volume":"80","author":"AF Serpico","year":"2023","unstructured":"Serpico, A. F., Pisauro, C. & Grieco, D. On the assembly of the mitotic spindle, bistability and hysteresis. Cell. Mol. Life Sci. 80, 83 (2023).","journal-title":"Cell. Mol. Life Sci."},{"key":"2940_CR69","doi-asserted-by":"publisher","first-page":"13427","DOI":"10.1073\/pnas.1400892111","volume":"111","author":"F Foijer","year":"2014","unstructured":"Foijer, F. et al. Chromosome instability induced by Mps1 and p53 mutation generates aggressive lymphomas exhibiting aneuploidy-induced stress. Proc. Natl. Acad. Sci. USA 111, 13427\u201313432 (2014).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2940_CR70","doi-asserted-by":"publisher","DOI":"10.1126\/science.aan2507","volume":"357","author":"M Uhlen","year":"2017","unstructured":"Uhlen, M. et al. A pathology atlas of the human cancer transcriptome. Science 357, eaan2507 (2017).","journal-title":"Science"},{"key":"2940_CR71","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1053\/j.gastro.2013.06.001","volume":"145","author":"RM de Voer","year":"2013","unstructured":"de Voer, R. M. et al. Germline mutations in the spindle assembly checkpoint genes BUB1 and BUB3 are risk factors for colorectal cancer. Gastroenterology 145, 544\u2013547 (2013).","journal-title":"Gastroenterology"},{"key":"2940_CR72","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1002\/1098-2264(2000)9999:9999<::AID-GCC1044>3.0.CO;2-N","volume":"29","author":"MJ Percy","year":"2000","unstructured":"Percy, M. J. et al. Expression and mutational analyses of the human MAD2L1 gene in breast cancer cells. Genes Chromosomes Cancer 29, 356\u2013362 (2000).","journal-title":"Genes Chromosomes Cancer"},{"key":"2940_CR73","doi-asserted-by":"publisher","first-page":"4684","DOI":"10.1074\/jbc.M115.672642","volume":"291","author":"Z He","year":"2016","unstructured":"He, Z. et al. JMJD5 (Jumonji Domain-containing 5) associates with spindle microtubules and is required for proper mitosis. J. Biol. Chem. 291, 4684\u20134697 (2016).","journal-title":"J. Biol. Chem."},{"key":"2940_CR74","doi-asserted-by":"publisher","first-page":"108929","DOI":"10.1016\/j.celrep.2021.108929","volume":"34","author":"S Yatskevich","year":"2021","unstructured":"Yatskevich, S. et al. Molecular mechanisms of APC\/C release from spindle assembly checkpoint inhibition by APC\/C SUMOylation. Cell Rep. 34, 108929 (2021).","journal-title":"Cell Rep."},{"key":"2940_CR75","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1158\/0008-5472.CAN-06-3326","volume":"67","author":"Y Iwanaga","year":"2007","unstructured":"Iwanaga, Y. et al. Heterozygous deletion of mitotic arrest-deficient protein 1 (MAD1) increases the incidence of tumors in mice. Cancer Res. 67, 160\u2013166 (2007).","journal-title":"Cancer Res."},{"key":"2940_CR76","doi-asserted-by":"publisher","first-page":"E2205","DOI":"10.1073\/pnas.1201911109","volume":"109","author":"SD Ryan","year":"2012","unstructured":"Ryan, S. D. et al. Up-regulation of the mitotic checkpoint component Mad1 causes chromosomal instability and resistance to microtubule poisons. Proc. Natl. Acad. Sci. USA 109, E2205\u2013E2214 (2012).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2940_CR77","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1093\/carcin\/21.12.2293","volume":"21","author":"X Wang","year":"2000","unstructured":"Wang, X. et al. Correlation of defective mitotic checkpoint with aberrantly reduced expression of Mad2 protein in nasopharyngeal carcinoma cells. Carcinogenesis 21, 2293\u20132297 (2000).","journal-title":"Carcinogenesis"},{"key":"2940_CR78","first-page":"1662","volume":"62","author":"X Wang","year":"2002","unstructured":"Wang, X. et al. Significance of Mad2 expression to mitotic checkpoint control in ovarian cancer cells. Cancer Res. 62, 1662\u20131668 (2002).","journal-title":"Cancer Res."},{"key":"2940_CR79","doi-asserted-by":"publisher","first-page":"1017864","DOI":"10.3389\/fonc.2022.1017864","volume":"12","author":"F Xian","year":"2022","unstructured":"Xian, F., Yang, X. & Xu, G. Prognostic significance of CDC20 expression in malignancy patients: A meta-analysis. Front. Oncol. 12, 1017864 (2022).","journal-title":"Front. Oncol."},{"key":"2940_CR80","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1002\/cm.20316","volume":"8","author":"DA Brito","year":"2009","unstructured":"Brito, D. A. & Rieder, C. L. The ability to survive mitosis in the presence of microtubule poisons differs significantly between human nontransformed (RPE-1) and cancer (U2OS, HeLa) cells. Cell Motil. Cytoskeleton 8, 437\u2013447 (2009).","journal-title":"Cell Motil. Cytoskeleton"},{"key":"2940_CR81","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ccr.2008.07.002","volume":"12","author":"KE Gascoigne","year":"2008","unstructured":"Gascoigne, K. E. & Taylor, S. Cancer cells display profound intra and interline variation following prolonged exposure to antimitotic drugs. Cancer Cell 12, 111\u2013122 (2008).","journal-title":"Cancer Cell"},{"key":"2940_CR82","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1038\/s44319-024-00363-8","volume":"26","author":"S Zheng","year":"2025","unstructured":"Zheng, S. et al. High CDC20 levels increase sensitivity of cancer cells to MPS1 inhibitors. EMBO Rep. 26, 1036\u20131061 (2025).","journal-title":"EMBO Rep."},{"key":"2940_CR83","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.sbi.2020.11.002","volume":"66","author":"M Bornens","year":"2021","unstructured":"Bornens, M. Centrosome organization and functions. Curr. Opin. Struct. Biol. 66, 199\u2013206 (2021).","journal-title":"Curr. Opin. Struct. Biol."},{"key":"2940_CR84","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/nrm.2017.127","volume":"19","author":"EA Nigg","year":"2018","unstructured":"Nigg, E. A. & Holland, A. J. Once and only once: mechanisms of centriole duplication and their deregulation in disease. Nat. Rev. Mol. Cell Biol. 19, 297\u2013312 (2018).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2940_CR85","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10076","volume":"6","author":"J Kim","year":"2015","unstructured":"Kim, J., Lee, K. & Rhee, K. PLK1 regulation of PCNT cleavage ensures fidelity of centriole separation during mitotic exit. Nat. Commun. 6, 10076 (2015).","journal-title":"Nat. Commun."},{"key":"2940_CR86","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11584-0","volume":"10","author":"T Wilhelm","year":"2019","unstructured":"Wilhelm, T. et al. Mild replication stress causes chromosome mis-segregation via premature centriole disengagement. Nat. Commun. 10, 3585 (2019).","journal-title":"Nat. Commun."},{"key":"2940_CR87","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/ncb2958","volume":"16","author":"H Maiato","year":"2014","unstructured":"Maiato, H. & Logarinho, E. Mitotic spindle multipolarity without centrosome amplification. Nat. Cell Biol. 16, 386\u2013394 (2014).","journal-title":"Nat. Cell Biol."},{"key":"2940_CR88","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41568-018-0084-6","volume":"19","author":"SMA Lens","year":"2019","unstructured":"Lens, S. M. A. & Medema, R. H. Cytokinesis defects and cancer. Nat. Rev. Cancer 19, 32\u201345 (2019).","journal-title":"Nat. Rev. Cancer"},{"key":"2940_CR89","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.molonc.2011.05.003","volume":"5","author":"A Kr\u00e4mer","year":"2011","unstructured":"Kr\u00e4mer, A., Maier, B. & Bartek, J. Centrosome clustering and chromosomal (in)stability: a matter of life and death. Mol. Oncol. 5, 324\u2013335 (2011).","journal-title":"Mol. Oncol."},{"key":"2940_CR90","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1016\/j.celrep.2017.08.005","volume":"20","author":"MR Cosenza","year":"2017","unstructured":"Cosenza, M. R. et al. Asymmetric centriole numbers at spindle poles cause chromosome missegregation in cancer. Cell Rep. 20, 1906\u20131920 (2017).","journal-title":"Cell Rep."},{"key":"2940_CR91","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/nrm4025","volume":"16","author":"S Santaguida","year":"2015","unstructured":"Santaguida, S. & Amon, A. Short- and long-term effects of chromosome mis-segregation and aneuploidy. Nat. Rev. Mol. Cell Biol. 16, 473\u2013485 (2015).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2940_CR92","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1242\/jcs.115.3.507","volume":"115","author":"D Cimini","year":"2002","unstructured":"Cimini, D., Fioravanti, D., Salmon, E. D. & Degrassi, F. Merotelic kinetochore orientation versus chromosome mono-orientation in the origin of lagging chromosomes in human primary cells. J. Cell Sci. 115, 507\u2013515 (2002).","journal-title":"J. Cell Sci."},{"key":"2940_CR93","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1091\/mbc.e11-02-0095","volume":"23","author":"WT Silkworth","year":"2012","unstructured":"Silkworth, W. T., Nardi, I. K., Paul, R., Mogilner, A. & Cimini, D. Timing of centrosome separation is important for accurate chromosome segregation. Mol. Biol. Cell 23, 401\u2013411 (2012).","journal-title":"Mol. Biol. Cell"},{"key":"2940_CR94","doi-asserted-by":"publisher","first-page":"4362","DOI":"10.1172\/JCI63084","volume":"122","author":"Y Zhang","year":"2012","unstructured":"Zhang, Y. et al. USP44 regulates centrosome positioning to prevent aneuploidy and suppress tumorigenesis. J. Clin. Investig. 122, 4362\u20134374 (2012).","journal-title":"J. Clin. Investig."},{"key":"2940_CR95","doi-asserted-by":"publisher","first-page":"10138","DOI":"10.1158\/0008-5472.CAN-07-0326","volume":"67","author":"A Castillo","year":"2007","unstructured":"Castillo, A. et al. Overexpression of Eg5 causes genomic instability and tumor formation in mice. Cancer Res. 67, 10138\u201310147 (2007).","journal-title":"Cancer Res."},{"key":"2940_CR96","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nature11941","volume":"495","author":"J Li","year":"2013","unstructured":"Li, J. et al. USP33 regulates centrosome biogenesis via deubiquitination of the centriolar protein CP110. Nature 495, 255\u2013259 (2013).","journal-title":"Nature"},{"key":"2940_CR97","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/nature09140","volume":"466","author":"V D\u2019Angiolella","year":"2010","unstructured":"D\u2019Angiolella, V. et al. SCF(Cyclin F) controls centrosome homeostasis and mitotic fidelity through CP110 degradation. Nature 466, 138\u2013142 (2010).","journal-title":"Nature"},{"key":"2940_CR98","doi-asserted-by":"publisher","first-page":"6626","DOI":"10.1038\/sj.onc.1208804","volume":"24","author":"M Buchholz","year":"2005","unstructured":"Buchholz, M. et al. Transcriptome analysis of microdissected pancreatic intraepithelial neoplastic lesions. Oncogene 24, 6626\u20136636 (2005).","journal-title":"Oncogene"},{"key":"2940_CR99","doi-asserted-by":"publisher","first-page":"150209","DOI":"10.1098\/rsob.150209","volume":"5","author":"PA Coelho","year":"2015","unstructured":"Coelho, P. A. et al. Over-expression of Plk4 induces centrosome amplification, loss of primary cilia and associated tissue hyperplasia in the mouse. Open Biol. 5, 150209 (2015).","journal-title":"Open Biol."},{"key":"2940_CR100","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.1016\/j.cub.2014.08.061","volume":"24","author":"NS Dzhindzhev","year":"2014","unstructured":"Dzhindzhev, N. S. et al. Plk4 phosphorylates Ana2 to trigger Sas6 recruitment and procentriole formation. Curr. Biol. 24, 2526\u20132532 (2014).","journal-title":"Curr. Biol."},{"key":"2940_CR101","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.cub.2008.11.037","volume":"19","author":"I Cunha-Ferreira","year":"2009","unstructured":"Cunha-Ferreira, I. et al. The SCF\/Slimb ubiquitin ligase limits centrosome amplification through degradation of SAK\/PLK4. Curr. Biol. 19, 43\u201349 (2009).","journal-title":"Curr. Biol."},{"key":"2940_CR102","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.cub.2007.01.049","volume":"17","author":"DM Duelli","year":"2007","unstructured":"Duelli, D. M. et al. A virus causes cancer by inducing massive chromosomal instability through cell fusion. Curr. Biol. 17, 431\u2013437 (2007).","journal-title":"Curr. Biol."},{"key":"2940_CR103","doi-asserted-by":"publisher","first-page":"102159","DOI":"10.1016\/j.gde.2024.102159","volume":"85","author":"NL Rittenhouse","year":"2024","unstructured":"Rittenhouse, N. L. & Dowen, J. M. Cohesin regulation and roles in chromosome structure and function. Curr. Opin. Genet. Dev. 85, 102159 (2024).","journal-title":"Curr. Opin. Genet. Dev."},{"key":"2940_CR104","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/S0092-8674(00)00132-X","volume":"103","author":"IC Waizenegger","year":"2000","unstructured":"Waizenegger, I. C., Hauf, S., Meinke, A. & Peters, J. M. Two distinct pathways remove mammalian cohesin from chromosome arms in prophase and from centromeres in anaphase. Cell 103, 399\u2013410 (2000).","journal-title":"Cell"},{"key":"2940_CR105","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/s41568-020-0270-1","volume":"20","author":"T Waldman","year":"2020","unstructured":"Waldman, T. Emerging themes in cohesin cancer biology. Nat. Rev. Cancer 20, 504\u2013515 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"2940_CR106","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3389\/fgene.2012.00171","volume":"3","author":"JA Horsfield","year":"2012","unstructured":"Horsfield, J. A., Print, C. G. & M\u00f6nnich, M. Diverse developmental disorders from the one ring: distinct molecular pathways underlie the cohesinopathies. Front. Genet 3, 171 (2012).","journal-title":"Front. Genet"},{"key":"2940_CR107","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/S0092-8674(03)00162-4","volume":"112","author":"S Gruber","year":"2003","unstructured":"Gruber, S., Haering, C. H. & Nasmyth, K. Chromosomal cohesin forms a ring. Cell 112, 765\u2013777 (2003).","journal-title":"Cell"},{"key":"2940_CR108","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.gde.2020.02.024","volume":"61","author":"A Cuadrado","year":"2020","unstructured":"Cuadrado, A. & Losada, A. Specialized functions of cohesins STAG1 and STAG2 in 3D genome architecture. Curr. Opin. Genet. Dev. 61, 9\u201316 (2020).","journal-title":"Curr. Opin. Genet. Dev."},{"key":"2940_CR109","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/S0092-8674(01)00603-1","volume":"107","author":"O Stemmann","year":"2001","unstructured":"Stemmann, O., Zou, H., Gerber, S. A., Gygi, S. P. & Kirschner, M. W. Dual inhibition of sister chromatid separation at metaphase. Cell 107, 715\u2013726 (2001).","journal-title":"Cell"},{"key":"2940_CR110","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.molcel.2005.05.022","volume":"19","author":"IH Gorr","year":"2005","unstructured":"Gorr, I. H., Boos, D. & Stemmann, O. Mutual inhibition of separase and Cdk1 by two-step complex formation. Mol. Cell 19, 135\u2013141 (2005).","journal-title":"Mol. Cell"},{"key":"2940_CR111","doi-asserted-by":"publisher","first-page":"13033","DOI":"10.1073\/pnas.0801610105","volume":"105","author":"N Zhang","year":"2008","unstructured":"Zhang, N. et al. Overexpression of separase induces aneuploidy and mammary tumorigenesis. Proc. Natl. Acad. Sci. USA 105, 13033\u201313038 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2940_CR112","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.1158\/1078-0432.CCR-08-2454","volume":"15","author":"R Meyer","year":"2009","unstructured":"Meyer, R. et al. Overexpression and mislocalization of the chromosomal segregation protein separase in multiple human cancers. Clin. Cancer Res. 15, 2703\u20132710 (2009).","journal-title":"Clin. Cancer Res."},{"key":"2940_CR113","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s10549-014-3070-z","volume":"147","author":"P Finetti","year":"2014","unstructured":"Finetti, P. et al. ESPL1 is a candidate oncogene of luminal B breast cancers. Breast Cancer Res. Treat. 147, 51\u201359 (2014).","journal-title":"Breast Cancer Res. Treat."},{"key":"2940_CR114","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S0304-3835(03)00483-X","volume":"202","author":"L Christopoulou","year":"2003","unstructured":"Christopoulou, L., Moore, J. D. & Tyler-Smith, C. Over-expression of wild-type Securin leads to aneuploidy in human cells. Cancer Lett. 202, 213\u2013218 (2003).","journal-title":"Cancer Lett."},{"key":"2940_CR115","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/modpathol.3800382","volume":"18","author":"S Ogbagabriel","year":"2005","unstructured":"Ogbagabriel, S., Fernando, M., Waldman, F., Bose, S. & Heaney, A. P. Securin is overexpressed in breast cancer. Mod. Pathol. 18, 985\u2013990 (2005).","journal-title":"Mod. Pathol."},{"key":"2940_CR116","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/ng1060","volume":"33","author":"S Ramaswamy","year":"2003","unstructured":"Ramaswamy, S., Ross, K. N., Lander, E. S. & Golub, T. R. A molecular signature of metastasis in primary solid tumors. Nat. Genet. 33, 49\u201354 (2003).","journal-title":"Nat. Genet."},{"key":"2940_CR117","unstructured":"Guo, G. et al. Whole-genome and whole-exome sequencing of bladder cancer identifies frequent alterations in genes involved in sister chromatid cohesion and segregation. Nat. Genet. 45, 1459\u20131463 (2013)."},{"key":"2940_CR118","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1038\/ng.2731","volume":"45","author":"A Kon","year":"2013","unstructured":"Kon, A. et al. Recurrent mutations in multiple components of the cohesin complex in myeloid neoplasms. Nat. Genet. 45, 1232\u20131237 (2013).","journal-title":"Nat. Genet."},{"key":"2940_CR119","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1004475","volume":"10","author":"AS Brohl","year":"2014","unstructured":"Brohl, A. S. et al. The genomic landscape of the Ewing Sarcoma family of tumors reveals recurrent STAG2 mutation. PLoS Genet. 10, e1004475 (2014).","journal-title":"PLoS Genet."},{"key":"2940_CR120","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1158\/2159-8290.CD-13-1037","volume":"4","author":"BD Crompton","year":"2014","unstructured":"Crompton, B. D. et al. The genomic landscape of pediatric Ewing sarcoma. Cancer Discov. 4, 1326\u20131341 (2014).","journal-title":"Cancer Discov."},{"key":"2940_CR121","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1182\/blood-2014-04-567057","volume":"124","author":"S Thota","year":"2014","unstructured":"Thota, S. et al. Genetic alterations of the cohesin complex genes in myeloid malignancies. Blood 124, 1790\u20131798 (2014).","journal-title":"Blood"},{"key":"2940_CR122","doi-asserted-by":"publisher","first-page":"3443","DOI":"10.1073\/pnas.0712384105","volume":"105","author":"TD Barber","year":"2008","unstructured":"Barber, T. D. et al. Chromatid cohesion defects may underlie chromosome instability in human colorectal cancers. Proc. Natl. Acad. Sci. USA 105, 3443\u20133448 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2940_CR123","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s13046-022-02321-5","volume":"41","author":"M Di Nardo","year":"2022","unstructured":"Di Nardo, M., Pallotta, M. M. & Musio, A. The multifaceted roles of cohesin in cancer. J. Exp. Clin. Cancer Res. 41, 96 (2022).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"2940_CR124","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1093\/nar\/gky519","volume":"47","author":"D Carvajal-Maldonado","year":"2019","unstructured":"Carvajal-Maldonado, D. et al. Perturbing cohesin dynamics drives MRE11 nuclease-dependent replication fork slowing. Nucleic Acids Res. 47, 1294\u20131310 (2019).","journal-title":"Nucleic Acids Res."},{"key":"2940_CR125","doi-asserted-by":"publisher","first-page":"e1009435","DOI":"10.1371\/journal.pgen.1009435","volume":"17","author":"ZM Carico","year":"2021","unstructured":"Carico, Z. M., Stefan, H. C., Justice, M., Yimit, A. & Dowen, J. M. A cohesin cancer mutation reveals a role for the hinge domain in genome organization and gene expression. PLoS Genet. 17, e1009435 (2021).","journal-title":"PLoS Genet."},{"key":"2940_CR126","doi-asserted-by":"publisher","DOI":"10.1093\/genetics\/iyab025","volume":"217","author":"NL Rittenhouse","year":"2021","unstructured":"Rittenhouse, N. L. et al. Functional impact of cancer-associated cohesin variants on gene expression and cellular identity. Genetics 217, iyab025 (2021).","journal-title":"Genetics"},{"key":"2940_CR127","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1016\/j.molcel.2022.05.004","volume":"82","author":"S Saxena","year":"2022","unstructured":"Saxena, S. & Zou, L. Hallmarks of DNA replication stress. Mol. Cell 82, 2298\u20132314 (2022).","journal-title":"Mol. Cell"},{"key":"2940_CR128","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/j.molcel.2019.04.027","volume":"74","author":"D Cortez","year":"2019","unstructured":"Cortez, D. Replication-coupled DNA Repair. Mol. Cell 74, 866\u2013876 (2019).","journal-title":"Mol. Cell"},{"key":"2940_CR129","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.gde.2021.07.003","volume":"71","author":"A Simoneau","year":"2021","unstructured":"Simoneau, A. & Zou, L. An extending ATR-CHK1 circuitry: the replication stress response and beyond. Curr. Opin. Genet. Dev. 71, 92\u201398 (2021).","journal-title":"Curr. Opin. Genet. Dev."},{"key":"2940_CR130","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/35087613","volume":"412","author":"M Lopes","year":"2001","unstructured":"Lopes, M. et al. The DNA replication checkpoint response stabilizes stalled replication forks. Nature 412, 557\u2013561 (2001).","journal-title":"Nature"},{"key":"2940_CR131","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.molcel.2015.02.031","volume":"58","author":"YH Chen","year":"2015","unstructured":"Chen, Y. H. et al. ATR-mediated phosphorylation of FANCI regulates dormant origin firing in response to replication stress. Mol. Cell 58, 323\u2013338 (2015).","journal-title":"Mol. Cell"},{"key":"2940_CR132","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.molcel.2010.07.015","volume":"39","author":"S Lambert","year":"2010","unstructured":"Lambert, S. et al. Homologous recombination restarts blocked replication forks at the expense of genome rearrangements by template exchange. Mol. Cell 39, 346\u2013359 (2010).","journal-title":"Mol. Cell"},{"key":"2940_CR133","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.molcel.2015.07.030","volume":"59","author":"H Dungrawala","year":"2015","unstructured":"Dungrawala, H. et al. The replication checkpoint prevents two types of fork collapse without regulating replisome stability. Mol. Cell 59, 998\u20131010 (2015).","journal-title":"Mol. Cell"},{"key":"2940_CR134","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.molcel.2015.07.029","volume":"59","author":"R Buisson","year":"2015","unstructured":"Buisson, R., Boisvert, J. L., Benes, C. H. & Zou, L. Distinct but concerted roles of ATR, DNA-PK, and Chk1 in countering replication stress during S phase. Mol. Cell 59, 1011\u20131024 (2015).","journal-title":"Mol. Cell"},{"key":"2940_CR135","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00018-019-03365-1","volume":"77","author":"Y Sun","year":"2020","unstructured":"Sun, Y., McCorvie, T. J., Yates, L. A. & Zhang, X. Structural basis of homologous recombination. Cell. Mol. Life Sci. 77, 3\u201318 (2020).","journal-title":"Cell. Mol. Life Sci."},{"key":"2940_CR136","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nrm.2017.48","volume":"18","author":"HHY Chang","year":"2017","unstructured":"Chang, H. H. Y., Pannunzio, N. R., Adachi, N. & Lieber, M. R. Nonhomologous DNA end joining and alternative pathways to double-strand break repair. Nat. Rev. Mol. Cell Biol. 18, 495\u2013506 (2017).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2940_CR137","first-page":"73","volume":"711","author":"JA Neal","year":"2011","unstructured":"Neal, J. A. & Meek, K. Choosing the right path: does DNA-PK help make the decision? Mutat. Res. 711, 73\u201386 (2011).","journal-title":"Mutat. Res."},{"key":"2940_CR138","doi-asserted-by":"publisher","first-page":"909","DOI":"10.15252\/embj.201693860","volume":"35","author":"J Michl","year":"2016","unstructured":"Michl, J., Zimmer, J. & Tarsounas, J. Interplay between Fanconi anemia and homologous recombination pathways in genome integrity. EMBO J. 35, 909\u2013923 (2016).","journal-title":"EMBO J."},{"key":"2940_CR139","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.dnarep.2018.08.017","volume":"71","author":"A Ait Saada","year":"2018","unstructured":"Ait Saada, A., Lambert, S. A. E. & Carr, A. M. Preserving replication fork integrity and competence via the homologous recombination pathway. DNA Repair 71, 135\u2013147 (2018).","journal-title":"DNA Repair"},{"key":"2940_CR140","doi-asserted-by":"publisher","first-page":"111836","DOI":"10.1016\/j.celrep.2022.111836","volume":"41","author":"N B\u00f6hly","year":"2022","unstructured":"B\u00f6hly, N. et al. Increased replication origin firing links replication stress to whole chromosomal instability in human cancer. Cell Rep. 41, 111836 (2022).","journal-title":"Cell Rep."},{"key":"2940_CR141","doi-asserted-by":"publisher","first-page":"e247811","DOI":"10.1001\/jamanetworkopen.2024.7811","volume":"7","author":"S Torres-Esquius","year":"2024","unstructured":"Torres-Esquius, S. et al. Prevalence of homologous recombination deficiency among patients with germline RAD51C\/D breast or ovarian cancer. JAMA Netw. Open 7, e247811 (2024).","journal-title":"JAMA Netw. Open"},{"key":"2940_CR142","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1146\/annurev-cancerbio-030617-050422","volume":"3","author":"J Niraj","year":"2019","unstructured":"Niraj, J., F\u00e4rkkil\u00e4, A. & D\u2019Andrea, A. D. The Fanconi anemia pathway in cancer. Annu. Rev. Cancer Biol. 3, 457\u2013478 (2019).","journal-title":"Annu. Rev. Cancer Biol."},{"key":"2940_CR143","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41568-018-0034-3","volume":"18","author":"E Lecona","year":"2018","unstructured":"Lecona, E. & Fernandez-Capetillo, O. Targeting ATR in cancer. Nat. Rev. Cancer 18, 586\u2013595 (2018).","journal-title":"Nat. Rev. Cancer"},{"key":"2940_CR144","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/s41580-021-00394-2","volume":"22","author":"JH Lee","year":"2021","unstructured":"Lee, J. H. & Paull, T. T. Cellular functions of the protein kinase ATM and their relevance to human disease. Nat. Rev. Mol. Cell Biol. 22, 796\u2013814 (2021).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2940_CR145","doi-asserted-by":"publisher","first-page":"3127","DOI":"10.1093\/hmg\/ddh335","volume":"13","author":"GK Alderton","year":"2004","unstructured":"Alderton, G. K. et al. Seckel syndrome exhibits cellular features demonstrating defects in the ATR-signalling pathway. Hum. Mol. Genet. 13, 3127\u20133138 (2004).","journal-title":"Hum. Mol. Genet."},{"key":"2940_CR146","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/S1535-6108(03)00110-7","volume":"3","author":"J Bartek","year":"2003","unstructured":"Bartek, J. & Lukas, J. Chk1 and Chk2 kinases in checkpoint control and cancer. Cancer Cell 3, 421\u2013429 (2003).","journal-title":"Cancer Cell"},{"key":"2940_CR147","doi-asserted-by":"publisher","first-page":"220011","DOI":"10.1098\/rsob.220011","volume":"12","author":"R Lu","year":"2022","unstructured":"Lu, R. & Pickett, H. A. Telomeric replication stress: the beginning and the end for alternative lengthening of telomeres cancers. Open Biol. 12, 220011 (2022).","journal-title":"Open Biol."},{"key":"2940_CR148","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.tibs.2022.03.013","volume":"47","author":"KA Brenner","year":"2022","unstructured":"Brenner, K. A. & Nandakumar, J. Consequences of telomere replication failure: the other end-replication problem. Trends Biochem. Sci. 47, 506\u2013517 (2022).","journal-title":"Trends Biochem. Sci."},{"key":"2940_CR149","doi-asserted-by":"publisher","first-page":"615","DOI":"10.3390\/genes9120615","volume":"9","author":"EM Black","year":"2018","unstructured":"Black, E. M. & Giunta, S. Repetitive Fragile sites: centromere satellite DNA as a source of genome instability in human diseases. Genes 9, 615 (2018).","journal-title":"Genes"},{"key":"2940_CR150","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1080\/15384101.2016.1242962","volume":"16","author":"AW Grenfell","year":"2017","unstructured":"Grenfell, A. W., Strzelecka, M. & Heald, R. Transcription brings the complex(ity) to the centromere. Cell Cycle 16, 235\u2013236 (2017).","journal-title":"Cell Cycle"},{"key":"2940_CR151","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1016\/j.cell.2016.09.053","volume":"167","author":"S Hamperl","year":"2016","unstructured":"Hamperl, S. & Cimprich, K. A. Conflict resolution in the genome: how transcription and replication make it work. Cell 167, 1455\u20131467 (2016).","journal-title":"Cell"},{"key":"2940_CR152","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/j.molcel.2011.10.013","volume":"44","author":"A Helmrich","year":"2011","unstructured":"Helmrich, A., Ballarino, M. & Tora, L. Collisions between replication and transcription complexes cause common fragile site instability. Mol. Cell 44, 966\u2013977 (2011).","journal-title":"Mol. Cell"},{"key":"2940_CR153","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1126\/science.aan6490","volume":"359","author":"L Kabeche","year":"2018","unstructured":"Kabeche, L., Nguyen, H. D., Buisson, R. & Zou, L. A mitosis-specific and R loop-driven ATR pathway promotes faithful chromosome segregation. Science 359, 108\u2013114 (2018).","journal-title":"Science"},{"key":"2940_CR154","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1083\/jcb.201611087","volume":"217","author":"GOM Bobkov","year":"2018","unstructured":"Bobkov, G. O. M., Gilbert, N. & Heun, P. Centromere transcription allows CENP-A to transit from chromatin association to stable incorporation. J. Cell Biol. 217, 1957\u20131972 (2018).","journal-title":"J. Cell Biol."},{"key":"2940_CR155","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2015634118","volume":"118","author":"S Giunta","year":"2021","unstructured":"Giunta, S. et al. CENP-A chromatin prevents replication stress at centromeres to avoid structural aneuploidy. Proc. Natl. Acad. Sci. USA 118, e2015634118 (2021).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2940_CR156","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1038\/s41588-018-0165-1","volume":"50","author":"CM Bielski","year":"2018","unstructured":"Bielski, C. M. et al. Genome doubling shapes the evolution and prognosis of advanced cancers. Nat. Genet. 50, 1189\u20131195 (2018).","journal-title":"Nat. Genet."},{"key":"2940_CR157","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/s41586-022-04578-4","volume":"604","author":"S Gemble","year":"2022","unstructured":"Gemble, S. et al. Genetic instability from a single S phase after whole-genome duplication. Nature 604, 146\u2013151 (2022).","journal-title":"Nature"},{"key":"2940_CR158","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/nrc3219","volume":"12","author":"KH Chow","year":"2012","unstructured":"Chow, K. H., Factor, R. E. & Ullman, K. S. The nuclear envelope environment and its cancer connections. Nat. Rev. Cancer 12, 196\u2013209 (2012).","journal-title":"Nat. Rev. Cancer"},{"key":"2940_CR159","doi-asserted-by":"publisher","first-page":"3210","DOI":"10.1091\/mbc.E16-02-0098","volume":"27","author":"S Lim","year":"2016","unstructured":"Lim, S., Quinton, R. J. & Ganem, N. J. Nuclear envelope rupture drives genome instability in cancer. Mol. Biol. Cell. 27, 3210\u20133213 (2016).","journal-title":"Mol. Biol. Cell."},{"key":"2940_CR160","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.cub.2020.11.037","volume":"31","author":"P Shah","year":"2021","unstructured":"Shah, P. et al. Nuclear deformation causes DNA damage by increasing replication stress. Curr. Biol. 31, 753\u2013765.e6 (2021).","journal-title":"Curr. Biol."},{"key":"2940_CR161","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1038\/s41588-025-02324-w","volume":"57","author":"C Salinas-Luypaert","year":"2025","unstructured":"Salinas-Luypaert, C. et al. DNA methylation influences human centromere positioning and function. Nat. Genet. 57, 2509\u20132521 (2025).","journal-title":"Nat. Genet."},{"key":"2940_CR162","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1158\/2159-8290.CD-25-0947","volume":"16","author":"Y Bai","year":"2026","unstructured":"Bai, Y. et al. Epigenetic regulation of chromosomal instability by EZH2 Methyltransferase. Cancer Discov. 16, 135\u2013154 (2026).","journal-title":"Cancer Discov."},{"key":"2940_CR163","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/nrm.2015.5","volume":"17","author":"KL McKinley","year":"2016","unstructured":"McKinley, K. L. & Cheeseman, I. M. The molecular basis for centromere identity and function. Nat. Rev. Mol. Cell Biol. 17, 16\u201329 (2016).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2940_CR164","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/s41586-024-07278-3","volume":"629","author":"GA Logsdon","year":"2024","unstructured":"Logsdon, G. A. et al. The variation and evolution of complete human centromeres. Nature 629, 136\u2013145 (2024).","journal-title":"Nature"},{"key":"2940_CR165","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.tig.2021.05.002","volume":"37","author":"A Nishiyama","year":"2021","unstructured":"Nishiyama, A. & Nakanishi, M. Navigating the DNA methylation landscape of cancer. Trends Genet 37, 1012\u20131027 (2021).","journal-title":"Trends Genet"},{"key":"2940_CR166","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/S0002-9440(10)61718-X","volume":"159","author":"N Wong","year":"2001","unstructured":"Wong, N. et al. Hypomethylation of chromosome 1 heterochromatin DNA correlates with q-arm copy gain in human hepatocellular carcinoma. Am. J. Pathol. 159, 465\u2013471 (2001).","journal-title":"Am. J. Pathol."},{"key":"2940_CR167","doi-asserted-by":"publisher","first-page":"6694","DOI":"10.1038\/sj.onc.1205890","volume":"21","author":"M Ehrlich","year":"2002","unstructured":"Ehrlich, M. et al. Hypomethylation and hypermethylation of DNA in Wilms tumors. Oncogene 21, 6694\u20136702 (2002).","journal-title":"Oncogene"},{"key":"2940_CR168","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1093\/hmg\/ddy130","volume":"27","author":"G Velasco","year":"2018","unstructured":"Velasco, G. et al. Comparative methylome analysis of ICF patients identifies heterochromatin loci that require ZBTB24, CDCA7 and HELLS for their methylated state. Hum. Mol. Genet. 27, 2409\u20132424 (2018).","journal-title":"Hum. Mol. Genet."},{"key":"2940_CR169","doi-asserted-by":"publisher","first-page":"4881","DOI":"10.1158\/0008-5472.CAN-17-1240","volume":"77","author":"M Takada","year":"2017","unstructured":"Takada, M. et al. FBW7 Loss promotes chromosomal instability and tumorigenesis via cyclin E1\/CDK2-mediated phosphorylation of CENP-A. Cancer Res. 77, 4881\u20134893 (2017).","journal-title":"Cancer Res."},{"key":"2940_CR170","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01548-2","volume":"21","author":"J Fan","year":"2022","unstructured":"Fan, J. et al. Clinical significance of FBXW7 loss of function in human cancers. Mol. Cancer 21, 87 (2022).","journal-title":"Mol. Cancer"},{"key":"2940_CR171","doi-asserted-by":"publisher","first-page":"5449","DOI":"10.1158\/0008-5472.CAN-20-2147","volume":"80","author":"ML Eich","year":"2020","unstructured":"Eich, M. L., Athar, M., Ferguson, J. E. III & Varambally, S. EZH2-targeted therapies in cancer: hype or a reality. Cancer Res. 80, 5449\u20135458 (2020).","journal-title":"Cancer Res."},{"key":"2940_CR172","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/s41580-021-00341-1","volume":"22","author":"A Piunti","year":"2021","unstructured":"Piunti, A. & Shilatifard, A. The roles of Polycomb repressive complexes in mammalian development and cancer. Nat. Rev. Mol. Cell Biol. 22, 326\u2013345 (2021).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2940_CR173","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ccr.2010.10.035","volume":"19","author":"CJ Chang","year":"2011","unstructured":"Chang, C. J. et al. EZH2 promotes expansion of breast tumor initiating cells through activation of RAF1-\u03b2-catenin signaling. Cancer Cell 19, 86\u2013100 (2011).","journal-title":"Cancer Cell"},{"key":"2940_CR174","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.tcb.2024.06.008","volume":"35","author":"V Kalamara","year":"2024","unstructured":"Kalamara, V. & Garinis, G. A. The epitranscriptome: reshaping the DNA damage response. Trends Cell Biol. 35, 294\u2013304 (2024).","journal-title":"Trends Cell Biol."},{"key":"2940_CR175","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s11033-026-11699-w","volume":"53","author":"EP Ahi","year":"2026","unstructured":"Ahi, E. P. & Ghasemishahrestani, Z. Epitranscriptomic control of telomere maintenance. Mol. Biol. Rep. 53, 513 (2026).","journal-title":"Mol. Biol. Rep."},{"key":"2940_CR176","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41588-019-0549-x","volume":"52","author":"A Abakir","year":"2020","unstructured":"Abakir, A. et al. N6-methyladenosine regulates the stability of RNA:DNA hybrids in human cells. Nat. Genet. 52, 48\u201355 (2020).","journal-title":"Nat. Genet."},{"key":"2940_CR177","doi-asserted-by":"publisher","first-page":"2848","DOI":"10.1038\/s41375-025-02765-6","volume":"39","author":"M Eleftheriou","year":"2025","unstructured":"Eleftheriou, M., Russell, J. & Tzelepis, K. Epitranscriptomic advances in normal and malignant hematopoiesis. Leukemia 39, 2848\u20132857 (2025).","journal-title":"Leukemia"},{"key":"2940_CR178","doi-asserted-by":"publisher","first-page":"1706557","DOI":"10.3389\/fimmu.2025.1706557","volume":"16","author":"X Zhao","year":"2025","unstructured":"Zhao, X. & Guan, S. Epitranscriptomic control of cancer immunity and therapy resistance. Front. Immunol. 16, 1706557 (2025).","journal-title":"Front. Immunol."},{"key":"2940_CR179","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1126\/science.1210214","volume":"333","author":"A Janssen","year":"2011","unstructured":"Janssen, A., van der Burg, M., Szuhai, K., Kops, G. J. P. L. & Medema, R. H. Chromosome segregation errors as a cause of DNA damage and structural chromosome aberrations. Science 333, 1895\u20131898 (2011).","journal-title":"Science"},{"key":"2940_CR180","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nature14493","volume":"522","author":"CZ Zhang","year":"2015","unstructured":"Zhang, C. Z. et al. Chromothripsis from DNA damage in micronuclei. Nature 522, 179\u2013184 (2015).","journal-title":"Nature"},{"key":"2940_CR181","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1002679","volume":"8","author":"J Pampalona","year":"2012","unstructured":"Pampalona, J., Fr\u00edas, C., Genesc\u00e0, A. & Tusell, L. Progressive telomere dysfunction causes cytokinesis failure and leads to the accumulation of polyploid cells. PLoS Genet. 8, e1002679 (2012).","journal-title":"PLoS Genet."},{"key":"2940_CR182","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s10555-013-9436-6","volume":"32","author":"TA Potapova","year":"2013","unstructured":"Potapova, T. A., Zhu, J. & Li, R. Aneuploidy and chromosomal instability: a vicious cycle driving cellular evolution and cancer genome chaos. Cancer Metastasis Rev. 32, 377\u2013389 (2013).","journal-title":"Cancer Metastasis Rev."},{"key":"2940_CR183","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37095-7","volume":"14","author":"L Garribba","year":"2013","unstructured":"Garribba, L. et al. Short-term molecular consequences of chromosome mis-segregation for genome stability. Nat. Commun. 14, 1353 (2013).","journal-title":"Nat. Commun."},{"key":"2940_CR184","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/msb.2012.40","volume":"8","author":"S Stingele","year":"2012","unstructured":"Stingele, S. et al. Global analysis of genome, transcriptome and proteome reveals the response to aneuploidy in human cells. Mol. Syst. Biol. 8, 608 (2012).","journal-title":"Mol. Syst. Biol."},{"key":"2940_CR185","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.devcel.2018.02.002","volume":"44","author":"J Zhu","year":"2018","unstructured":"Zhu, J., Tsai, H. J., Gordon, M. R. & Li, R. Cellular stress associated with aneuploidy. Dev. Cell 44, 420\u2013431 (2018).","journal-title":"Dev. Cell"},{"key":"2940_CR186","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.devcel.2016.01.008","volume":"36","author":"M Clemente-Ruiz","year":"2016","unstructured":"Clemente-Ruiz, M. et al. Gene dosage imbalance contributes to chromosomal instability-induced tumorigenesis. Dev. Cell 36, 290\u2013302 (2016).","journal-title":"Dev. Cell"},{"key":"2940_CR187","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1038\/s41588-019-0399-6","volume":"51","author":"ACF Bolhaqueiro","year":"2019","unstructured":"Bolhaqueiro, A. C. F. et al. Ongoing chromosomal instability and karyotype evolution in human colorectal cancer organoids. Nat. Genet. 51, 824\u2013834 (2019).","journal-title":"Nat. Genet."},{"key":"2940_CR188","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1038\/s41588-021-00891-2","volume":"53","author":"Y Bollen","year":"2021","unstructured":"Bollen, Y. et al. Reconstructing single-cell karyotype alterations in colorectal cancer identifies punctuated and gradual diversification patterns. Nat. Genet. 53, 1187\u20131195 (2021).","journal-title":"Nat. Genet."},{"key":"2940_CR189","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.1016\/j.celrep.2019.02.051","volume":"26","author":"G Laflamme","year":"2019","unstructured":"Laflamme, G. et al. Interphase microtubules safeguard mitotic progression by suppressing an aurora B-dependent arrest induced by DNA replication stress. Cell Rep. 26, 2875\u20132889.e3 (2019).","journal-title":"Cell Rep."},{"key":"2940_CR190","first-page":"28","volume":"730","author":"JP Murnane","year":"2012","unstructured":"Murnane, J. P. Telomere dysfunction and chromosome instability. Mutat. Res. 730, 28\u201336 (2012).","journal-title":"Mutat. Res."},{"key":"2940_CR191","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1002\/bies.201400104","volume":"36","author":"AJ Cesare","year":"2014","unstructured":"Cesare, A. J. Mitosis, double strand break repair, and telomeres: a view from the end: how telomeres and the DNA damage response cooperate during mitosis to maintain genome stability. Bioessays 36, 1054\u20131061 (2014).","journal-title":"Bioessays"},{"key":"2940_CR192","doi-asserted-by":"publisher","first-page":"3995","DOI":"10.1158\/0008-5472.CAN-18-3235","volume":"79","author":"DH Bach","year":"2019","unstructured":"Bach, D. H., Zhang, W. & Sood, A. K. Chromosomal instability in tumor initiation and development. Cancer Res. 79, 3995\u20134002 (2019).","journal-title":"Cancer Res."},{"key":"2940_CR193","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s41586-020-2698-6","volume":"587","author":"TBK Watkins","year":"2020","unstructured":"Watkins, T. B. K. et al. Pervasive chromosomal instability and karyotype order in tumour evolution. Nature 587, 126\u2013132 (2020).","journal-title":"Nature"},{"key":"2940_CR194","doi-asserted-by":"publisher","first-page":"14793","DOI":"10.1073\/pnas.1618215113","volume":"113","author":"C Gao","year":"2016","unstructured":"Gao, C. et al. Chromosome instability drives phenotypic switching to metastasis. Proc. Natl. Acad. Sci. USA 113, 14793\u201314798 (2016).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2940_CR195","doi-asserted-by":"publisher","first-page":"7704","DOI":"10.1158\/1078-0432.CCR-11-2049","volume":"17","author":"SF Bakhoum","year":"2011","unstructured":"Bakhoum, S. F., Danilova, O. V., Kaur, P., Levy, N. B. & Compton, D. A. Chromosomal instability substantiates poor prognosis in patients with diffuse large B-cell lymphoma. Clin. Cancer Res. 17, 7704\u20137711 (2011).","journal-title":"Clin. Cancer Res."},{"key":"2940_CR196","doi-asserted-by":"publisher","first-page":"3447","DOI":"10.1158\/0008-5472.CAN-10-3667","volume":"71","author":"NJ Birkbak","year":"2011","unstructured":"Birkbak, N. J. et al. Paradoxical relationship between chromosomal instability and survival outcome in cancer. Cancer Res. 71, 3447\u20133452 (2011).","journal-title":"Cancer Res."},{"key":"2940_CR197","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s00412-013-0414-0","volume":"122","author":"C Kuffer","year":"2013","unstructured":"Kuffer, C., Kuznetsova, A. Y. & Storchov\u00e1, Z. Abnormal mitosis triggers p53- dependent cell cycle arrest in human tetraploid cells. Chromosoma 122, 305\u2013318 (2013).","journal-title":"Chromosoma"},{"key":"2940_CR198","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/s41586-019-0885-0","volume":"565","author":"J Nassour","year":"2019","unstructured":"Nassour, J. et al. Autophagic cell death restricts chromosomal instability during replicative crisis. Nature 565, 659\u2013663 (2019).","journal-title":"Nature"},{"key":"2940_CR199","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1038\/s41586-023-06464-z","volume":"620","author":"J Li","year":"2023","unstructured":"Li, J. et al. Non-cell-autonomous cancer progression from chromosomal instability. Nature 620, 1080\u20131088 (2023).","journal-title":"Nature"},{"key":"2940_CR200","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1158\/0008-5472.CAN-10-3604","volume":"71","author":"AJX Lee","year":"2011","unstructured":"Lee, A. J. X. et al. Chromosomal instability confers intrinsic multidrug resistance. Cancer Res. 71, 1858\u20131870 (2011).","journal-title":"Cancer Res."},{"key":"2940_CR201","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13039-019-0429-1","volume":"12","author":"AE Tijhuis","year":"2019","unstructured":"Tijhuis, A. E., Johnson, S. C. & McClelland, S. E. The emerging links between chromosomal instability (CIN), metastasis, inflammation and tumour immunity. Mol. Cytogenet. 12, 17 (2019).","journal-title":"Mol. Cytogenet."},{"key":"2940_CR202","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/s41420-022-01202-2","volume":"8","author":"L Iuliano","year":"2022","unstructured":"Iuliano, L. et al. Proteotoxic stress-induced apoptosis in cancer cells: understanding the susceptibility and enhancing the potency. Cell Death Discov. 8, 407 (2022).","journal-title":"Cell Death Discov."},{"key":"2940_CR203","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1101\/gad.269118.115","volume":"29","author":"S Santaguida","year":"2015","unstructured":"Santaguida, S., Vasile, E., White, E. & Amon, A. Aneuploidy-induced cellular stresses limit autophagic degradation. Genes Dev. 29, 2010\u20132021 (2015).","journal-title":"Genes Dev."},{"key":"2940_CR204","doi-asserted-by":"publisher","first-page":"a033951","DOI":"10.1101\/cshperspect.a033951","volume":"12","author":"GG Jayaraj","year":"2020","unstructured":"Jayaraj, G. G., Hipp, M. S. & Hartl, F. U. Functional modules of the proteostasis network. Cold Spring Harb. Perspect. Biol. 12, a033951 (2020).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"2940_CR205","doi-asserted-by":"publisher","first-page":"e976491","DOI":"10.4161\/23723556.2014.976491","volume":"2","author":"N Donnelly","year":"2015","unstructured":"Donnelly, N. & Storchov\u00e1, Z. Aneuploidy and proteotoxic stress in cancer. Mol. Cell. Oncol. 2, e976491 (2015).","journal-title":"Mol. Cell. Oncol."},{"key":"2940_CR206","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.75227","volume":"11","author":"P Cheng","year":"2022","unstructured":"Cheng, P. et al. Proteogenomic analysis of cancer aneuploidy and normal tissues reveals divergent modes of gene regulation across cellular pathways. Elife 11, e75227 (2022).","journal-title":"Elife"},{"key":"2940_CR207","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33904-7","volume":"13","author":"G Yahya","year":"2022","unstructured":"Yahya, G. et al. Sublinear scaling of the cellular proteome with ploidy. Nat. Commun. 13, 6182 (2022).","journal-title":"Nat. Commun."},{"key":"2940_CR208","doi-asserted-by":"publisher","DOI":"10.1186\/s12915-020-00852-x","volume":"18","author":"KE Larrimore","year":"2020","unstructured":"Larrimore, K. E., Barattin-Voynova, N. S., Reid, D. W. & Ng, D. T. W. Aneuploidy-induced proteotoxic stress can be effectively tolerated without dosage compensation, genetic mutations, or stress responses. BMC Biol. 18, 117 (2020).","journal-title":"BMC Biol."},{"key":"2940_CR209","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41580-020-0250-z","volume":"21","author":"C Hetz","year":"2020","unstructured":"Hetz, C., Zhang, K. & Kaufman, R. J. Mechanisms, regulation and functions of the unfolded protein response. Nat. Rev. Mol. Cell Biol. 21, 421\u2013438 (2020).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2940_CR210","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/35014014","volume":"2","author":"A Bertolotti","year":"2000","unstructured":"Bertolotti, A., Zhang, Y., Hendershot, L. M., Harding, H. P. & Ron, D. Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response. Nat. Cell Biol. 2, 326\u2013332 (2000).","journal-title":"Nat. Cell Biol."},{"key":"2940_CR211","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.molcel.2017.06.017","volume":"69","author":"C Hetz","year":"2018","unstructured":"Hetz, C. & Papa, F. R. The unfolded protein response and cell fate control. Mol. Cell. 69, 169\u2013181 (2018).","journal-title":"Mol. Cell."},{"key":"2940_CR212","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1101\/gad.327494.119","volume":"33","author":"CM Brennan","year":"2019","unstructured":"Brennan, C. M. et al. Protein aggregation mediates stoichiometry of protein complexes in aneuploid cells. Genes Dev. 33, 1031\u20131047 (2019).","journal-title":"Genes Dev."},{"key":"2940_CR213","doi-asserted-by":"publisher","first-page":"20932","DOI":"10.1073\/pnas.0710370104","volume":"104","author":"J Bean","year":"2007","unstructured":"Bean, J. et al. MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib. Proc. Natl. Acad. Sci. USA 104, 20932\u201320937 (2007).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2940_CR214","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1158\/2159-8290.CD-23-0309","volume":"14","author":"MR Ippolito","year":"2024","unstructured":"Ippolito, M. R. et al. Increased RNA and protein degradation is required for counteracting transcriptional burden and proteotoxic stress in human aneuploid cells. Cancer Discov. 14, 2532\u20132553 (2024).","journal-title":"Cancer Discov."},{"key":"2940_CR215","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1038\/s44318-025-00372-w","volume":"44","author":"JE B\u00f6kenkamp","year":"2025","unstructured":"B\u00f6kenkamp, J. E. et al. Proteogenomic analysis reveals adaptive strategies for alleviating the consequences of aneuploidy in cancer. EMBO J. 44, 1829\u20131865 (2025).","journal-title":"EMBO J."},{"key":"2940_CR216","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.molcel.2010.10.006","volume":"40","author":"K Richter","year":"2010","unstructured":"Richter, K., Haslbeck, M. & Buchner, J. The heat shock response: life on the verge of death. Mol. Cell. 40, 253\u2013266 (2010).","journal-title":"Mol. Cell."},{"key":"2940_CR217","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.cell.2012.06.031","volume":"150","author":"ML Mendillo","year":"2012","unstructured":"Mendillo, M. L. et al. HSF1 drives a transcriptional program distinct from heat shock to support highly malignant human cancers. Cell 150, 549\u2013562 (2012).","journal-title":"Cell"},{"key":"2940_CR218","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.molcel.2016.01.013","volume":"61","author":"YS Yun","year":"2016","unstructured":"Yun, Y. S. et al. mTORC1 coordinates protein synthesis and immunoproteasome formation via PRAS40 to prevent accumulation of protein stress. Mol. Cell. 61, 625\u2013639 (2016).","journal-title":"Mol. Cell."},{"key":"2940_CR219","doi-asserted-by":"publisher","DOI":"10.1126\/science.abn4180","volume":"381","author":"X Lv","year":"2023","unstructured":"Lv, X. et al. Modulation of the proteostasis network promotes tumor resistance to oncogenic KRAS inhibitors. Science 381, eabn4180 (2023).","journal-title":"Science"},{"key":"2940_CR220","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/s41589-019-0291-9","volume":"15","author":"P Tsvetkov","year":"2019","unstructured":"Tsvetkov, P. et al. Mitochondrial metabolism promotes adaptation to proteotoxic stress. Nat. Chem. Biol. 15, 681\u2013689 (2019).","journal-title":"Nat. Chem. Biol."},{"key":"2940_CR221","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646\u2013674 (2011).","journal-title":"Cell"},{"key":"2940_CR222","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41568-021-00378-6","volume":"21","author":"I Mart\u00ednez-Reyes","year":"2021","unstructured":"Mart\u00ednez-Reyes, I. & Chandel, N. S. Cancer metabolism: looking forward. Nat. Rev. Cancer 21, 669\u2013680 (2021).","journal-title":"Nat. Rev. Cancer"},{"key":"2940_CR223","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","volume":"324","author":"MG Vander Heiden","year":"2009","unstructured":"Vander Heiden, M. G., Cantley, L. C. & Thompson, C. B. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324, 1029\u20131033 (2009).","journal-title":"Science"},{"key":"2940_CR224","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/nrc2468","volume":"8","author":"NC Denko","year":"2008","unstructured":"Denko, N. C. Hypoxia, HIF1 and glucose metabolism in the solid tumour. Nat. Rev. Cancer 8, 705\u2013713 (2008).","journal-title":"Nat. Rev. Cancer"},{"key":"2940_CR225","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1016\/j.cell.2015.08.016","volume":"162","author":"CH Chang","year":"2015","unstructured":"Chang, C. H. et al. Metabolic competition in the tumor microenvironment is a driver of cancer progression. Cell 162, 1229\u20131241 (2015).","journal-title":"Cell"},{"key":"2940_CR226","doi-asserted-by":"publisher","first-page":"1563303","DOI":"10.3389\/fimmu.2025.1563303","volume":"16","author":"XY Gu","year":"2025","unstructured":"Gu, X. Y. et al. Impact of lactate on immune cell function in the tumor microenvironment: mechanisms and therapeutic perspectives. Front. Immunol. 16, 1563303 (2025).","journal-title":"Front. Immunol."},{"key":"2940_CR227","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1016\/j.devcel.2021.06.009","volume":"56","author":"J Joy","year":"2021","unstructured":"Joy, J. et al. Proteostasis failure and mitochondrial dysfunction leads to aneuploidy-induced senescence. Dev. Cell. 56, 2043\u20132058.e2047 (2021).","journal-title":"Dev. Cell."},{"key":"2940_CR228","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1089\/ars.2009.2625","volume":"11","author":"CXC Santos","year":"2009","unstructured":"Santos, C. X. C., Tanaka, L. Y., Wosniak, J. & Laurindo, F. R. M. Mechanisms and implications of reactive oxygen species generation during the unfolded protein response: roles of endoplasmic reticulum oxidoreductases, mitochondrial electron transport, and NADPH oxidase. Antioxid. Redox Signal. 11, 2409\u20132427 (2009).","journal-title":"Antioxid. Redox Signal."},{"key":"2940_CR229","doi-asserted-by":"publisher","first-page":"101084","DOI":"10.1016\/j.redox.2018.101084","volume":"25","author":"US Srinivas","year":"2019","unstructured":"Srinivas, U. S., Tan, B. W. Q., Vellayappan, B. A. & Jeyasekharan, A. D. ROS and the DNA damage response in cancer. Redox Biol. 25, 101084 (2019).","journal-title":"Redox Biol."},{"key":"2940_CR230","first-page":"3107","volume":"63","author":"CL Limoli","year":"2003","unstructured":"Limoli, C. L. et al. Persistent oxidative stress in chromosomally unstable cells. Cancer Res. 63, 3107\u20133111 (2003).","journal-title":"Cancer Res."},{"key":"2940_CR231","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.freeradbiomed.2009.05.026","volume":"47","author":"WC Burhans","year":"2009","unstructured":"Burhans, W. C. & Heintz, N. H. The cell cycle is a redox cycle: linking phase-specific targets to cell fate. Free Radic. Biol. Med. 47, 1282\u20131293 (2009).","journal-title":"Free Radic. Biol. Med."},{"key":"2940_CR232","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-019-0961-y","volume":"18","author":"Z Liao","year":"2019","unstructured":"Liao, Z., Chua, D. & Tan, N. S. Reactive oxygen species: a volatile driver of field cancerization and metastasis. Mol. Cancer 18, 1\u201310 (2019).","journal-title":"Mol. Cancer"},{"key":"2940_CR233","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1111\/cas.13537","volume":"109","author":"H Kitamura","year":"2018","unstructured":"Kitamura, H. & Motohashi, H. NRF2 addiction in cancer cells. Cancer Sci. 109, 900\u2013911 (2018).","journal-title":"Cancer Sci."},{"key":"2940_CR234","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/s42255-023-00832-9","volume":"5","author":"A Cheng","year":"2023","unstructured":"Cheng, A. et al. A mitotic NADPH upsurge promotes chromosome segregation and tumour progression in aneuploid cancer cells. Nat. Metab. 5, 1141\u20131158 (2023).","journal-title":"Nat. Metab."},{"key":"2940_CR235","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/s41580-021-00436-9","volume":"23","author":"R Li","year":"2022","unstructured":"Li, R. & Zhu, J. Effects of aneuploidy on cell behaviour and function. Nat. Rev. Mol. Cell Biol. 23, 250\u2013265 (2022).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2940_CR236","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/s12276-023-00971-9","volume":"55","author":"J Jin","year":"2023","unstructured":"Jin, J., Byun, J. K., Choi, Y. K. & Park, K. G. Targeting glutamine metabolism as a therapeutic strategy for cancer. Exp. Mol. Med. 55, 706\u2013715 (2023).","journal-title":"Exp. Mol. Med."},{"key":"2940_CR237","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2021108130","volume":"40","author":"O Kepp","year":"2021","unstructured":"Kepp, O. et al. ATP and cancer immunosurveillance. EMBO J. 40, e108130 (2021).","journal-title":"EMBO J."},{"key":"2940_CR238","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01733-x","volume":"22","author":"C Xia","year":"2023","unstructured":"Xia, C., Yin, S., To, K. K. W. & Fu, L. CD39\/CD73\/A2AR pathway and cancer immunotherapy. Mol. Cancer 22, 44 (2023).","journal-title":"Mol. Cancer"},{"key":"2940_CR239","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1083\/jcb.200905057","volume":"188","author":"SL Thompson","year":"2010","unstructured":"Thompson, S. L. & Compton, D. A. Proliferation of aneuploid human cells is limited by a p53-dependent mechanism. J. Cell Biol. 188, 369\u2013381 (2010).","journal-title":"J. Cell Biol."},{"key":"2940_CR240","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1016\/j.celrep.2017.05.055","volume":"19","author":"M Soto","year":"2017","unstructured":"Soto, M. et al. p53 prohibits propagation of chromosome segregation errors that produce structural aneuploidies. Cell Rep. 19, 2423\u20132431 (2017).","journal-title":"Cell Rep."},{"key":"2940_CR241","doi-asserted-by":"publisher","first-page":"642","DOI":"10.3390\/metabo13050642","volume":"13","author":"A Islam","year":"2023","unstructured":"Islam, A. et al. Chromosomal instability causes sensitivity to polyamines and one-carbon metabolism. Metabolites 13, 642 (2023).","journal-title":"Metabolites"},{"key":"2940_CR242","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/ncb3348","volume":"18","author":"EH Hinchcliffe","year":"2016","unstructured":"Hinchcliffe, E. H. et al. Chromosome missegregation during anaphase triggers p53 cell cycle arrest through histone H3.3 Ser31 phosphorylation. Nat. Cell Biol. 18, 668\u2013675 (2016).","journal-title":"Nat. Cell Biol."},{"key":"2940_CR243","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1101\/gad.289728.116","volume":"31","author":"LL Fava","year":"2017","unstructured":"Fava, L. L. et al. The PIDDosome activates p53 in response to supernumerary centrosomes. Genes Dev. 31, 34\u201345 (2017).","journal-title":"Genes Dev."},{"key":"2940_CR244","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/ncb1529","volume":"9","author":"K Mikule","year":"2007","unstructured":"Mikule, K. et al. Loss of centrosome integrity induces p38-p53-p21-dependent G1-S arrest. Nat. Cell Biol. 9, 160\u2013170 (2007).","journal-title":"Nat. Cell Biol."},{"key":"2940_CR245","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/cdd.2017.169","volume":"25","author":"BJ Aubrey","year":"2018","unstructured":"Aubrey, B. J., Kelly, G. L., Janic, A., Herold, M. J. & Strasser, A. How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression? Cell Death Differ. 25, 104\u2013113 (2018).","journal-title":"Cell Death Differ."},{"key":"2940_CR246","first-page":"7660","volume":"61","author":"PR Andreassen","year":"2001","unstructured":"Andreassen, P. R., Lacroix, F. B., Lohez, O. D. & Margolis, R. L. Neither p21WAF1 nor 14-3-3sigma prevents G2 progression to mitotic catastrophe in human colon carcinoma cells after DNA damage, but p21WAF1 induces stable G1 arrest in resulting tetraploid cells. Cancer Res. 61, 7660\u20137668 (2001).","journal-title":"Cancer Res."},{"key":"2940_CR247","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.devcel.2017.05.022","volume":"41","author":"S Santaguida","year":"2017","unstructured":"Santaguida, S. et al. Chromosome Mis-segregation generates cell-cycle-arrested cells with complex karyotypes that are eliminated by the immune system. Dev. Cell. 41, 638\u2013651.e5 (2017).","journal-title":"Dev. Cell."},{"key":"2940_CR248","doi-asserted-by":"publisher","first-page":"4114","DOI":"10.1038\/sj.onc.1208579","volume":"24","author":"P Hemmati","year":"2005","unstructured":"Hemmati, P. et al. Loss of p21 disrupts p14ARF-induced G1 cell cycle arrest but augments p14ARF-induced apoptosis in human carcinoma cells. Oncogene 24, 4114\u20134128 (2005).","journal-title":"Oncogene"},{"key":"2940_CR249","doi-asserted-by":"publisher","first-page":"3207","DOI":"10.1038\/sj.onc.1205429","volume":"21","author":"H Weber","year":"2002","unstructured":"Weber, H. et al. Human p14ARF-mediated cell cycle arrest strictly depends on intact p53 signaling pathways. Oncogene 21, 3207\u20133212 (2002).","journal-title":"Oncogene"},{"key":"2940_CR250","doi-asserted-by":"publisher","first-page":"824","DOI":"10.3390\/genes11070824","volume":"11","author":"D Cilluffo","year":"2020","unstructured":"Cilluffo, D., Barra, V. & Di Leonardo, A. P14ARF: the absence that makes the difference. Genes 11, 824 (2020).","journal-title":"Genes"},{"key":"2940_CR251","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1002\/ijc.25511","volume":"127","author":"P Ozenne","year":"2010","unstructured":"Ozenne, P., Eymin, B., Brambilla, E. & Gazzeri, S. The ARF tumor suppressor: Structure, functions and status in cancer. Int. J. Cancer 127, 2239\u20132247 (2010).","journal-title":"Int. J. Cancer"},{"key":"2940_CR252","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1083\/jcb.201604054","volume":"214","author":"BG Lambrus","year":"2016","unstructured":"Lambrus, B. G. et al. A USP28-53BP1-p53-p21 signaling axis arrests growth after centrosome loss or prolonged mitosis. J. Cell Biol. 214, 143\u2013153 (2016).","journal-title":"J. Cell Biol."},{"key":"2940_CR253","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1126\/science.add9528","volume":"383","author":"F Meitinger","year":"2024","unstructured":"Meitinger, F. et al. Control of cell proliferation by memories of mitosis. Science 383, 1441\u20131448 (2024).","journal-title":"Science"},{"key":"2940_CR254","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41556-024-01565-x","volume":"27","author":"S Herv\u00e9","year":"2025","unstructured":"Herv\u00e9, S. et al. Chromosome mis-segregation triggers cell cycle arrest through a mechanosensitive nuclear envelope checkpoint. Nat. Cell Biol. 27, 73\u201386 (2025).","journal-title":"Nat. Cell Biol."},{"key":"2940_CR255","doi-asserted-by":"publisher","first-page":"110400","DOI":"10.1016\/j.jbiomech.2021.110400","volume":"121","author":"AB Roberts","year":"2021","unstructured":"Roberts, A. B. et al. Tumor cell nuclei soften during transendothelial migration. J. Biomech. 121, 110400 (2021).","journal-title":"J. Biomech."},{"key":"2940_CR256","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.ccell.2018.03.007","volume":"33","author":"AM Taylor","year":"2018","unstructured":"Taylor, A. M. et al. Genomic and functional approaches to understanding cancer aneuploidy. Cancer Cell 33, 676\u2013689.e3 (2018).","journal-title":"Cancer Cell"},{"key":"2940_CR257","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.cell.2019.05.035","volume":"178","author":"C Zierhut","year":"2019","unstructured":"Zierhut, C. et al. The cytoplasmic DNA sensor cGAS promotes mitotic cell death. Cell 178, 302\u2013315.e323 (2019).","journal-title":"Cell"},{"key":"2940_CR258","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1158\/2159-8290.CD-23-1073","volume":"14","author":"M Di Bona","year":"2024","unstructured":"Di Bona, M. & Bakhoum, S. F. Micronuclei and cancer. Cancer Discov. 14, 214\u2013226 (2024).","journal-title":"Cancer Discov."},{"key":"2940_CR259","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.cell.2013.06.007","volume":"154","author":"EM Hatch","year":"2013","unstructured":"Hatch, E. M., Fischer, A. H., Deerinck, T. J. & Hetzer, M. W. Catastrophic nuclear envelope collapse in cancer cell micronuclei. Cell 154, 47\u201360 (2013).","journal-title":"Cell"},{"key":"2940_CR260","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/s41586-018-0534-z","volume":"561","author":"S Liu","year":"2018","unstructured":"Liu, S. et al. Nuclear envelope assembly defects link mitotic errors to chromothripsis. Nature 561, 551\u2013555 (2018).","journal-title":"Nature"},{"key":"2940_CR261","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/nature23449","volume":"548","author":"KJ Mackenzie","year":"2017","unstructured":"Mackenzie, K. J. et al. cGAS surveillance of micronuclei links genome instability to innate immunity. Nature 548, 461\u2013465 (2017).","journal-title":"Nature"},{"key":"2940_CR262","doi-asserted-by":"publisher","DOI":"10.1126\/science.adj8691","volume":"385","author":"M Di Bona","year":"2024","unstructured":"Di Bona, M. et al. Micronuclear collapse from oxidative damage. Science 385, eadj8691 (2024).","journal-title":"Science"},{"key":"2940_CR263","doi-asserted-by":"publisher","DOI":"10.1126\/science.adj7446","volume":"385","author":"S Martin","year":"2024","unstructured":"Martin, S. et al. A p62-dependent rheostat dictates micronuclei catastrophe and chromosome rearrangements. Science 385, eadj7446 (2024).","journal-title":"Science"},{"key":"2940_CR264","first-page":"35","volume":"729","author":"M Terradas","year":"2012","unstructured":"Terradas, M., Mart\u00edn, M., Hern\u00e1ndez, L., Tusell, L. & Genesc\u00e0, A. Nuclear envelope defects impede a proper response to micronuclear DNA lesions. Mutat. Res. 729, 35\u201340 (2012).","journal-title":"Mutat. Res."},{"key":"2940_CR265","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/s41586-023-06084-7","volume":"619","author":"AS Agustinus","year":"2023","unstructured":"Agustinus, A. S. et al. Epigenetic dysregulation from chromosomal transit in micronuclei. Nature 619, 176\u2013183 (2023).","journal-title":"Nature"},{"key":"2940_CR266","doi-asserted-by":"publisher","first-page":"jcs.214742","DOI":"10.1242\/jcs.214742","volume":"13","author":"M Soto","year":"2018","unstructured":"Soto, M., Garc\u00eda-Santisteban, I., Krenning, L., Medema, R. H. & Raaijmakers, J. A. Chromosomes trapped in micronuclei are liable to segregation errors. J. Cell Sci. 13, jcs.214742 (2018).","journal-title":"J. Cell Sci."},{"key":"2940_CR267","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41586-020-03064-z","volume":"591","author":"O Shoshani","year":"2021","unstructured":"Shoshani, O. et al. Chromothripsis drives the evolution of gene amplification in cancer. Nature 591, 137\u2013141 (2021).","journal-title":"Nature"},{"key":"2940_CR268","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/s41576-022-00521-5","volume":"23","author":"E Yi","year":"2022","unstructured":"Yi, E., Chamorro Gonz\u00e1lez, R., Henssen, A. G. & Verhaak, R. G. Extrachromosomal DNA amplifications in cancer. Nat. Rev. Genet. 23, 760\u2013771 (2022).","journal-title":"Nat. Rev. Genet."},{"key":"2940_CR269","doi-asserted-by":"publisher","first-page":"3960","DOI":"10.1093\/hmg\/ddx283","volume":"26","author":"K Bartsch","year":"2017","unstructured":"Bartsch, K. et al. Absence of RNase H2 triggers generation of immunogenic micronuclei removed by autophagy. Hum. Mol. Genet. 26, 3960\u20133972 (2017).","journal-title":"Hum. Mol. Genet."},{"key":"2940_CR270","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1002\/ijc.28467","volume":"134","author":"W Ji","year":"2014","unstructured":"Ji, W. et al. Expulsion of micronuclei containing amplified genes contributes to a decrease in double minute chromosomes from malignant tumor cells. Int. J. Cancer 134, 1279\u20131288 (2014).","journal-title":"Int. J. Cancer"},{"key":"2940_CR271","first-page":"81","volume":"448","author":"N Shimizu","year":"2000","unstructured":"Shimizu, N., Shimura, T. & Tanaka, T. Selective elimination of acentric double minutes from cancer cells through the extrusion of micronuclei. Mutat. Res. 448, 81\u201390 (2000).","journal-title":"Mutat. Res."},{"key":"2940_CR272","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/s41568-024-00769-5","volume":"25","author":"M Simovic-Lorenz","year":"2025","unstructured":"Simovic-Lorenz, M. & Ernst, A. Chromothripsis in cancer. Nat. Rev. Cancer 25, 79\u201392 (2025).","journal-title":"Nat. Rev. Cancer"},{"key":"2940_CR273","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1158\/2159-8290.CD-19-0761","volume":"10","author":"J Kwon","year":"2020","unstructured":"Kwon, J. & Bakhoum, S. F. The cytosolic DNA-sensing cGAS-STING pathway in cancer. Cancer Discov. 10, 26\u201339 (2020).","journal-title":"Cancer Discov."},{"key":"2940_CR274","doi-asserted-by":"publisher","first-page":"5328","DOI":"10.1128\/JVI.00037-14","volume":"88","author":"T Abe","year":"2014","unstructured":"Abe, T. & Barber, G. N. Cytosolic-DNA-mediated, STING-dependent proinflammatory gene induction necessitates canonical NF-\u03baB activation through TBK1. J. Virol. 88, 5328\u20135341 (2014).","journal-title":"J. Virol."},{"key":"2940_CR275","doi-asserted-by":"publisher","first-page":"e52032","DOI":"10.15252\/embr.202052032","volume":"22","author":"RW Wang","year":"2021","unstructured":"Wang, R. W., Vigano, S., Ben-David, U., Amon, A. & Santaguida, S. Aneuploid senescent cells activate NF-\u03baB to promote their immune clearance by NK cells. EMBO Rep. 22, e52032 (2021).","journal-title":"EMBO Rep."},{"key":"2940_CR276","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/nature25432","volume":"553","author":"SF Bakhoum","year":"2018","unstructured":"Bakhoum, S. F. et al. Chromosomal instability drives metastasis through a cytosolic DNA response. Nature 553, 467\u2013472 (2018).","journal-title":"Nature"},{"key":"2940_CR277","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/nature24050","volume":"550","author":"Z Dou","year":"2017","unstructured":"Dou, Z. et al. Cytoplasmic chromatin triggers inflammation in senescence and cancer. Nature 550, 402\u2013406 (2017).","journal-title":"Nature"},{"key":"2940_CR278","doi-asserted-by":"publisher","first-page":"420","DOI":"10.3390\/biom10030420","volume":"10","author":"M Mijit","year":"2020","unstructured":"Mijit, M., Caracciolo, V., Melillo, A., Amicarelli, F. & Giordano, A. Role of p53 in the regulation of cellular senescence. Biomolecules 10, 420 (2020).","journal-title":"Biomolecules"},{"key":"2940_CR279","doi-asserted-by":"publisher","first-page":"3333","DOI":"10.1002\/1878-0261.13268","volume":"16","author":"M Takasugi","year":"2022","unstructured":"Takasugi, M., Yoshida, Y. & Ohtani, N. Cellular senescence and the tumour microenvironment. Mol. Oncol. 16, 3333\u20133351 (2022).","journal-title":"Mol. Oncol."},{"key":"2940_CR280","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/s41580-024-00727-x","volume":"25","author":"B Wang","year":"2024","unstructured":"Wang, B., Han, J., Elisseeff, J. H. & Demaria, M. The senescence-associated secretory phenotype and its physiological and pathological implications. Nat. Rev. Mol. Cell Biol. 25, 958\u2013978 (2024).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2940_CR281","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1083\/jcb.201212110","volume":"202","author":"A Ivanov","year":"2013","unstructured":"Ivanov, A. et al. Lysosome-mediated processing of chromatin in senescence. J. Cell Biol. 202, 129\u2013143 (2013).","journal-title":"J. Cell Biol."},{"key":"2940_CR282","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.mad.2017.08.005","volume":"170","author":"G Nelson","year":"2018","unstructured":"Nelson, G., Kucheryavenko, O., Wordsworth, J. & von Zglinicki, T. The senescent bystander effect is caused by ROS-activated NF-\u03baB signalling. Mech. Ageing Dev. 170, 30\u201336 (2018).","journal-title":"Mech. Ageing Dev."},{"key":"2940_CR283","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15208","volume":"8","author":"YH Kim","year":"2017","unstructured":"Kim, Y. H. et al. Senescent tumor cells lead the collective invasion in thyroid cancer. Nat. Commun. 8, 15208 (2017).","journal-title":"Nat. Commun."},{"key":"2940_CR284","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1038\/ncb2784","volume":"15","author":"JC Acosta","year":"2013","unstructured":"Acosta, J. C. et al. A complex secretory program orchestrated by the inflammasome controls paracrine senescence. Nat. Cell Biol. 15, 978\u2013990 (2013).","journal-title":"Nat. Cell Biol."},{"key":"2940_CR285","doi-asserted-by":"publisher","first-page":"112129","DOI":"10.1016\/j.celrep.2023.112129","volume":"42","author":"S Matsuda","year":"2023","unstructured":"Matsuda, S. et al. TGF-\u03b2 in the microenvironment induces a physiologically occurring immune-suppressive senescent state. Cell Rep. 42, 112129 (2023).","journal-title":"Cell Rep."},{"key":"2940_CR286","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s10577-023-09730-y","volume":"10","author":"A van den Brink","year":"2023","unstructured":"van den Brink, A., Su\u00e1rez Peredo Rodr\u00edguez, M. F. & Foijer, F. Chromosomal instability and inflammation: a catch-22 for cancer cells. Chromosome Res. 10, 19 (2023).","journal-title":"Chromosome Res."},{"key":"2940_CR287","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaf8399","volume":"355","author":"T Davoli","year":"2017","unstructured":"Davoli, T., Uno, H., Wooten, E. C. & Elledge, S. J. Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy. Science 355, eaaf8399 (2017).","journal-title":"Science"},{"key":"2940_CR288","doi-asserted-by":"publisher","first-page":"895961","DOI":"10.3389\/fimmu.2022.895961","volume":"13","author":"X Kuang","year":"2022","unstructured":"Kuang, X. & Li, J. Chromosome instability and aneuploidy as context-dependent activators or inhibitors of antitumor immunity. Front. Immunol. 13, 895961 (2022).","journal-title":"Front. Immunol."},{"key":"2940_CR289","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-019-0684-0","volume":"11","author":"ER Mardis","year":"2019","unstructured":"Mardis, E. R. Neoantigens and genome instability: impact on immunogenomic phenotypes and immunotherapy response. Genome Med. 11, 71 (2019).","journal-title":"Genome Med."},{"key":"2940_CR290","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1126\/science.1203486","volume":"331","author":"RD Schreiber","year":"2011","unstructured":"Schreiber, R. D., Old, L. J. & Smyth, M. J. Cancer immunoediting: integrating immunity\u2019s roles in cancer suppression and promotion. Science 331, 1565\u20131570 (2011).","journal-title":"Science"},{"key":"2940_CR291","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1126\/science.1224922","volume":"337","author":"L Senovilla","year":"2012","unstructured":"Senovilla, L. et al. An immunosurveillance mechanism controls cancer cell ploidy. Science 337, 1678\u20131684 (2012).","journal-title":"Science"},{"key":"2940_CR292","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.immuni.2018.09.016","volume":"49","author":"A Marcus","year":"2018","unstructured":"Marcus, A. et al. Tumor-derived cGAMP triggers a STING-mediated interferon response in non-tumor cells to activate the NK cell response. Immunity 49, 754\u2013763.e4 (2018).","journal-title":"Immunity"},{"key":"2940_CR293","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/s43018-020-0028-4","volume":"1","author":"JA Carozza","year":"2020","unstructured":"Carozza, J. A. et al. Extracellular cGAMP is a cancer-cell-produced immunotransmitter involved in radiation-induced anti-cancer immunity. Nat. Cancer 1, 184\u2013196 (2020).","journal-title":"Nat. Cancer"},{"key":"2940_CR294","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11762","volume":"7","author":"MK Ruhland","year":"2016","unstructured":"Ruhland, M. K. et al. Stromal senescence establishes an immunosuppressive microenvironment that drives tumorigenesis. Nat. Commun. 7, 11762 (2016).","journal-title":"Nat. Commun."},{"key":"2940_CR295","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/s41586-022-04847-2","volume":"607","author":"C Hong","year":"2022","unstructured":"Hong, C. et al. cGAS\u2013STING drives the IL-6-dependent survival of chromosomally instable cancers. Nature 607, 366\u2013373 (2022).","journal-title":"Nature"},{"key":"2940_CR296","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.88054.3","volume":"12","author":"BH Hayes","year":"2024","unstructured":"Hayes, B. H. et al. Chromosomal instability induced in cancer can enhance macrophage-initiated immune responses that include anti-tumor IgG. Elife 12, RP88054 (2024).","journal-title":"Elife"},{"key":"2940_CR297","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03050-0","volume":"9","author":"Q Wang","year":"2018","unstructured":"Wang, Q. et al. Vascular niche IL-6 induces alternative macrophage activation in glioblastoma through HIF-2\u03b1. Nat. Commun. 9, 559 (2018).","journal-title":"Nat. Commun."},{"key":"2940_CR298","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/s41577-019-0127-6","volume":"19","author":"DG DeNardo","year":"2019","unstructured":"DeNardo, D. G. & Ruffell, B. Macrophages as regulators of tumour immunity and immunotherapy. Nat. Rev. Immunol. 19, 369\u2013382 (2019).","journal-title":"Nat. Rev. Immunol."},{"key":"2940_CR299","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/j.cell.2017.10.001","volume":"171","author":"N McGranahan","year":"2017","unstructured":"McGranahan, N. et al. Allele-specific HLA loss and immune escape in lung cancer evolution. Cell 171, 1259\u20131271.e11 (2017).","journal-title":"Cell"},{"key":"2940_CR300","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1038\/s41588-023-01367-1","volume":"55","author":"F Mart\u00ednez-Jim\u00e9nez","year":"2023","unstructured":"Mart\u00ednez-Jim\u00e9nez, F. et al. Genetic immune escape landscape in primary and metastatic cancer. Nat. Genet. 55, 820\u2013831 (2023).","journal-title":"Nat. Genet."},{"key":"2940_CR301","doi-asserted-by":"publisher","first-page":"1462296","DOI":"10.3389\/fimmu.2024.1462496","volume":"15","author":"M Requesens","year":"2024","unstructured":"Requesens, M., Foijer, F., Nijman, H. W. & de Bruyn, M. Genomic instability as a driver and suppressor of anti-tumor immunity. Front. Immunol. 15, 1462296 (2024).","journal-title":"Front. Immunol."},{"key":"2940_CR302","doi-asserted-by":"publisher","first-page":"100862","DOI":"10.1016\/j.tranon.2020.100862","volume":"13","author":"CY Huang","year":"2020","unstructured":"Huang, C. Y., Ye, Z. H., Huang, M. Y. & Lu, J. J. Regulation of CD47 expression in cancer cells. Transl. Oncol. 13, 100862 (2020).","journal-title":"Transl. Oncol."},{"key":"2940_CR303","doi-asserted-by":"publisher","first-page":"1699237","DOI":"10.3389\/fimmu.2025.1699237","volume":"16","author":"N van Buuren","year":"2025","unstructured":"van Buuren, N. et al. CD47 expression in solid tumors correlates with phagocytic tumor-associated macrophage gene signature. Front. Immunol. 16, 1699237 (2025).","journal-title":"Front. Immunol."},{"key":"2940_CR304","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1038\/nm.3337","volume":"19","author":"SM Pyonteck","year":"2013","unstructured":"Pyonteck, S. M. et al. CSF-1R inhibition alters macrophage polarization and blocks glioma progression. Nat. Med. 19, 1264\u20131272 (2013).","journal-title":"Nat. Med."},{"key":"2940_CR305","doi-asserted-by":"publisher","first-page":"114884","DOI":"10.1016\/j.ejmech.2022.114884","volume":"245","author":"J Wen","year":"2023","unstructured":"Wen, J., Wang, S., Guo, R. & Liu, D. CSF1R inhibitors are emerging immunotherapeutic drugs for cancer treatment. Eur. J. Med. Chem. 245, 114884 (2023).","journal-title":"Eur. J. Med. Chem."},{"key":"2940_CR306","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1158\/2159-8290.CD-20-0387","volume":"11","author":"J Li","year":"2021","unstructured":"Li, J. et al. Metastasis and immune evasion from extracellular cGAMP hydrolysis. Cancer Discov. 11, 1212\u20131227 (2021).","journal-title":"Cancer Discov."},{"key":"2940_CR307","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41392-025-02148-4","volume":"10","author":"Y Li","year":"2025","unstructured":"Li, Y. et al. Invasion and metastasis in cancer: molecular insights and therapeutic targets. Signal Transduct. Target. Ther. 10, 57 (2025).","journal-title":"Signal Transduct. Target. Ther."},{"key":"2940_CR308","doi-asserted-by":"publisher","first-page":"189060","DOI":"10.1016\/j.bbcan.2023.189060","volume":"1879","author":"D Dymerska","year":"2024","unstructured":"Dymerska, D. & Marusiak, A. A. Drivers of cancer metastasis \u2013 Arise early and remain present. Biochim. Biophys. Acta Rev. Cancer 1879, 189060 (2024).","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"2940_CR309","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/nature12625","volume":"501","author":"RA Burrell","year":"2013","unstructured":"Burrell, R. A., McGranahan, N., Bartek, J. & Swanton, C. The causes and consequences of genetic heterogeneity in cancer evolution. Nature 501, 338\u2013345 (2013).","journal-title":"Nature"},{"key":"2940_CR310","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/j.cell.2018.08.027","volume":"174","author":"SF Bakhoum","year":"2018","unstructured":"Bakhoum, S. F. & Cantley, L. C. The Multifaceted role of chromosomal instability in cancer and its microenvironment. Cell 174, 1347\u20131360 (2018).","journal-title":"Cell"},{"key":"2940_CR311","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1038\/s43018-021-00268-8","volume":"2","author":"SM W\u00f6rmann","year":"2021","unstructured":"W\u00f6rmann, S. M. et al. APOBEC3A drives deaminase domain-independent chromosomal instability to promote pancreatic cancer metastasis. Nat. Cancer 2, 1338\u20131356 (2021).","journal-title":"Nat. Cancer"},{"key":"2940_CR312","doi-asserted-by":"publisher","first-page":"3645","DOI":"10.1158\/0008-5472.CAN-07-2938","volume":"68","author":"TT Onder","year":"2008","unstructured":"Onder, T. T. et al. Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res. 68, 3645\u20133654 (2008).","journal-title":"Cancer Res."},{"key":"2940_CR313","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.ccell.2016.04.003","volume":"29","author":"Y Cai","year":"2016","unstructured":"Cai, Y. et al. Loss of chromosome 8p governs tumor progression and drug response by altering lipid metabolism. Cancer Cell 29, 751\u2013766 (2016).","journal-title":"Cancer Cell"},{"key":"2940_CR314","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29898-x","volume":"13","author":"C Lu","year":"2022","unstructured":"Lu, C. et al. Hypoxia-activated neuropeptide Y\/Y5 receptor\/RhoA pathway triggers chromosomal instability and bone metastasis in Ewing sarcoma. Nat. Commun. 13, 2323 (2022).","journal-title":"Nat. Commun."},{"key":"2940_CR315","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.devcel.2020.01.034","volume":"52","author":"A Vasudevan","year":"2020","unstructured":"Vasudevan, A. et al. Single-chromosomal gains can function as metastasis suppressors and promoters in colon cancer. Dev. Cell 52, 413\u2013428.e6 (2020).","journal-title":"Dev. Cell"},{"key":"2940_CR316","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.trecan.2021.09.002","volume":"8","author":"DA Lukow","year":"2022","unstructured":"Lukow, D. A. & Sheltzer, J. M. Chromosomal instability and aneuploidy as causes of cancer drug resistance. Trends Cancer 8, 43\u201353 (2022).","journal-title":"Trends Cancer"},{"key":"2940_CR317","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/j.molonc.2014.06.005","volume":"8","author":"RA Burrell","year":"2014","unstructured":"Burrell, R. A. & Swanton, C. Tumour heterogeneity and the evolution of polyclonal drug resistance. Mol. Oncol. 8, 1095\u20131111 (2014).","journal-title":"Mol. Oncol."},{"key":"2940_CR318","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s10555-024-10172-z","volume":"43","author":"GR Bhat","year":"2024","unstructured":"Bhat, G. R. et al. Cancer cell plasticity: from cellular, molecular, and genetic mechanisms to tumor heterogeneity and drug resistance. Cancer Metastasis Rev. 43, 197\u2013228 (2024).","journal-title":"Cancer Metastasis Rev."},{"key":"2940_CR319","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1016\/j.devcel.2021.07.006","volume":"56","author":"MR Ippolito","year":"2021","unstructured":"Ippolito, M. R. et al. Gene copy-number changes and chromosomal instability induced by aneuploidy confer resistance to chemotherapy. Dev. Cell. 56, 2440\u20132454.e6 (2021).","journal-title":"Dev. Cell."},{"key":"2940_CR320","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201910941","volume":"12","author":"L Salgueiro","year":"2020","unstructured":"Salgueiro, L. et al. Acquisition of chromosome instability is a mechanism to evade oncogene addiction. EMBO Mol. Med. 12, e10941 (2020).","journal-title":"EMBO Mol. Med."},{"key":"2940_CR321","doi-asserted-by":"publisher","DOI":"10.1186\/2050-7771-1-13","volume":"1","author":"S L\u00fc","year":"2013","unstructured":"L\u00fc, S. & Wang, J. The resistance mechanisms of proteasome inhibitor bortezomib. Biomark. Res. 1, 13 (2013).","journal-title":"Biomark. Res."},{"key":"2940_CR322","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/s41571-024-00923-w","volume":"21","author":"DH Al-Rawi","year":"2024","unstructured":"Al-Rawi, D. H., Lettera, E., Li, J., DiBona, M. & Bakhoum, S. F. Targeting chromosomal instability in patients with cancer. Nat. Rev. Clin. Oncol. 21, 645\u2013659 (2024).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"2940_CR323","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1158\/2159-8290.CD-16-1415","volume":"7","author":"ME Burkard","year":"2017","unstructured":"Burkard, M. E. & Weaver, B. A. Tuning chromosomal instability to optimize tumor fitness. Cancer Discov. 7, 134\u2013136 (2017).","journal-title":"Cancer Discov."},{"key":"2940_CR324","doi-asserted-by":"publisher","first-page":"E4134","DOI":"10.1073\/pnas.1317042110","volume":"110","author":"AD Silk","year":"2013","unstructured":"Silk, A. D. et al. Chromosome missegregation rate predicts whether aneuploidy will promote or suppress tumors. Proc. Natl. Acad. Sci. USA 110, E4134\u2013E4141 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2940_CR325","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms6990","volume":"6","author":"SF Bakhoum","year":"2015","unstructured":"Bakhoum, S. F. et al. Numerical chromosomal instability mediates susceptibility to radiation treatment. Nat. Commun. 6, 5990 (2015).","journal-title":"Nat. Commun."},{"key":"2940_CR326","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1042\/BST20220838","volume":"51","author":"B Beernaert","year":"2023","unstructured":"Beernaert, B. & Parkes, E. E. cGAS-STING signalling in cancer: striking a balance with chromosomal instability. Biochem. Soc. Trans. 51, 539\u2013555 (2023).","journal-title":"Biochem. Soc. Trans."},{"key":"2940_CR327","doi-asserted-by":"crossref","unstructured":"Lukow, A. D. et al. Chromosomal instability accelerates the evolution of resistance to anti-cancer therapies. Dev. Cell. 56, 2427\u20132439.e4 (2021).","DOI":"10.1016\/j.devcel.2021.07.009"},{"key":"2940_CR328","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.chembiol.2023.05.005","volume":"30","author":"QM Lv","year":"2023","unstructured":"Lv, Q. M. et al. Cancer cell-autonomous cGAS-STING response confers drug resistance. Cell Chem. Biol. 30, 591\u2013605 (2023).","journal-title":"Cell Chem. Biol."},{"key":"2940_CR329","doi-asserted-by":"publisher","first-page":"3976","DOI":"10.1080\/15548627.2021.1899440","volume":"17","author":"M Zhao","year":"2021","unstructured":"Zhao, M. et al. CGAS is a micronucleophagy receptor for the clearance of micronuclei. Autophagy 17, 3976\u20133991 (2021).","journal-title":"Autophagy"},{"key":"2940_CR330","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1038\/s41588-025-02226-x","volume":"57","author":"D Huang","year":"2025","unstructured":"Huang, D., Spurr, L. F., Weichselbaum, R. R. & Pitroda, S. P. Tumor aneuploidy as a prognostic and predictive biomarker in immune checkpoint blockade. Nat. Genet 57, 1802\u20131811 (2025).","journal-title":"Nat. Genet"},{"key":"2940_CR331","doi-asserted-by":"publisher","first-page":"642","DOI":"10.3390\/genes11060642","volume":"11","author":"T Wilhelm","year":"2020","unstructured":"Wilhelm, T., Said, M. & Naim, V. DNA replication stress and chromosomal instability: dangerous liaisons. Genes 11, 642 (2020).","journal-title":"Genes"},{"key":"2940_CR332","doi-asserted-by":"publisher","first-page":"2620184","DOI":"10.1080\/07853890.2026.2620184","volume":"58","author":"D Ma","year":"2026","unstructured":"Ma, D. et al. A system-level metastable model of cancer evolution: integrating replication stress, cell cycle deregulation and chromosomal instability. Ann. Med. 58, 2620184 (2026).","journal-title":"Ann. Med."},{"key":"2940_CR333","doi-asserted-by":"publisher","first-page":"bio038000","DOI":"10.1242\/bio.038000","volume":"7","author":"M Khan","year":"2018","unstructured":"Khan, M., Shaukat, Z., Saint, R. & Gregory, S. L. Chromosomal instability causes sensitivity to protein folding stress and ATP depletion. Biol. Open 7, bio038000 (2018).","journal-title":"Biol. Open"},{"key":"2940_CR334","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.semcdb.2013.02.001","volume":"24","author":"LM Zasadil","year":"2013","unstructured":"Zasadil, L. M., Britigan, E. M. & Weaver, B. A. 2n or not 2n: Aneuploidy, polyploidy and chromosomal instability in primary and tumor cells. Semin. Cell Dev. Biol. 24, 370\u2013379 (2013).","journal-title":"Semin. Cell Dev. Biol."},{"key":"2940_CR335","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1016\/j.celrep.2016.01.060","volume":"14","author":"T Wild","year":"2016","unstructured":"Wild, T. et al. The spindle assembly checkpoint is not essential for viability of human cells with genetically lowered APC\/C Activity. Cell Rep. 14, 1829\u20131840 (2016).","journal-title":"Cell Rep."},{"key":"2940_CR336","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.cell.2014.01.010","volume":"156","author":"V Rodriguez-Bravo","year":"2014","unstructured":"Rodriguez-Bravo, V. et al. Nuclear pores protect genome integrity by assembling a premitotic and Mad1-dependent anaphase inhibitor. Cell 156, 1017\u20131031 (2014).","journal-title":"Cell"},{"key":"2940_CR337","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1158\/2159-8290.CD-16-0645","volume":"7","author":"L Sansregret","year":"2017","unstructured":"Sansregret, L. et al. APC\/C dysfunction limits excessive cancer chromosomal instability. Cancer Discov. 7, 218\u2013233 (2017).","journal-title":"Cancer Discov."},{"key":"2940_CR338","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1158\/2159-8290.CD-13-0285","volume":"4","author":"SM Dewhurst","year":"2014","unstructured":"Dewhurst, S. M. et al. Tolerance of whole genome doubling propagates chromosomal instability and accelerates cancer genome evolution. Cancer Discov. 4, 175\u2013185 (2014).","journal-title":"Cancer Discov."},{"key":"2940_CR339","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/s41586-020-03133-3","volume":"590","author":"RJ Quinton","year":"2021","unstructured":"Quinton, R. J. et al. Whole-genome doubling confers unique genetic vulnerabilities on tumour cells. Nature 590, 492\u2013497 (2021).","journal-title":"Nature"},{"key":"2940_CR340","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21447-2","volume":"12","author":"C Marquis","year":"2021","unstructured":"Marquis, C. et al. Chromosomally unstable tumor cells specifically require KIF18A for proliferation. Nat. Commun. 12, 1213 (2021).","journal-title":"Nat. Commun."},{"key":"2940_CR341","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-55300-z","volume":"16","author":"AF Phillips","year":"2025","unstructured":"Phillips, A. F. et al. Targeting chromosomally unstable tumors with a selective KIF18A inhibitor. Nat. Commun. 16, 307 (2025).","journal-title":"Nat. Commun."},{"key":"2940_CR342","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1038\/s41586-022-05082-5","volume":"608","author":"T Baslan","year":"2022","unstructured":"Baslan, T. et al. Ordered and deterministic cancer genome evolution after p53 loss. Nature 608, 795\u2013802 (2022).","journal-title":"Nature"},{"key":"2940_CR343","first-page":"1129","volume":"62","author":"F Bunz","year":"2002","unstructured":"Bunz, F. et al. Targeted inactivation of p53 in human cells does not result in aneuploidy. Cancer Res. 62, 1129\u20131133 (2002).","journal-title":"Cancer Res."},{"key":"2940_CR344","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s10577-023-09741-9","volume":"31","author":"JF Marques","year":"2023","unstructured":"Marques, J. F. & Kops, G. J. P. L. Permission to pass: on the role of p53 as a gatekeeper for aneuploidy. Chromosome Res. 31, 31 (2023).","journal-title":"Chromosome Res."},{"key":"2940_CR345","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-52176-x","volume":"15","author":"J Zerbib","year":"2024","unstructured":"Zerbib, J. et al. Human aneuploid cells depend on the RAF\/MEK\/ERK pathway for overcoming increased DNA damage. Nat. Commun. 15, 7772 (2024).","journal-title":"Nat. Commun."},{"key":"2940_CR346","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ccell.2016.11.001","volume":"31","author":"C L\u00f3pez-Garc\u00eda","year":"2017","unstructured":"L\u00f3pez-Garc\u00eda, C. et al. BCL9L dysfunction impairs caspase-2 expression permitting aneuploidy tolerance in colorectal cancer. Cancer Cell 31, 79\u201393 (2017).","journal-title":"Cancer Cell"},{"key":"2940_CR347","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1038\/sj.cdd.4401912","volume":"13","author":"JC Marine","year":"2006","unstructured":"Marine, J. C. et al. Keeping p53 in check: essential and synergistic functions of Mdm2 and Mdm4. Cell Death Differ. 13, 927\u2013934 (2006).","journal-title":"Cell Death Differ."},{"key":"2940_CR348","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.tranon.2018.09.007","volume":"12","author":"A Quaas","year":"2019","unstructured":"Quaas, A. et al. Genomic Characterization of TP53-wild-type esophageal carcinoma. Transl. Oncol. 12, 154\u2013161 (2019).","journal-title":"Transl. Oncol."},{"key":"2940_CR349","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1093\/emboj\/18.1.22","volume":"18","author":"R Honda","year":"1999","unstructured":"Honda, R. & Yasuda, H. Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53. EMBO J. 18, 22\u201327 (1999).","journal-title":"EMBO J."},{"key":"2940_CR350","first-page":"129","volume":"60","author":"M Esteller","year":"2000","unstructured":"Esteller, M. et al. Hypermethylation-associated inactivation of p14(ARF) is independent of p16(INK4a) methylation and p53 mutational status. Cancer Res. 60, 129\u2013133 (2000).","journal-title":"Cancer Res."},{"key":"2940_CR351","doi-asserted-by":"publisher","first-page":"110569","DOI":"10.1016\/j.celrep.2022.110569","volume":"38","author":"JC Smith","year":"2022","unstructured":"Smith, J. C. & Sheltzer, J. M. Genome-wide identification and analysis of prognostic features in human cancers. Cell Rep. 38, 110569 (2022).","journal-title":"Cell Rep."},{"key":"2940_CR352","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1038\/nsmb.2189","volume":"18","author":"M Murga","year":"2011","unstructured":"Murga, M. et al. Exploiting oncogene-induced replicative stress for the selective killing of Myc-driven tumors. Nat. Struct. Mol. Biol. 18, 1331\u20131335 (2011).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"2940_CR353","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1080\/14728222.2021.1864321","volume":"25","author":"S Nayak","year":"2021","unstructured":"Nayak, S., Calvo, J. A. & Cantor, S. B. Targeting translesion synthesis (TLS) to expose replication gaps, a unique cancer vulnerability. Expert Opin. Ther. Targets 25, 27\u201336 (2021).","journal-title":"Expert Opin. Ther. Targets"},{"key":"2940_CR354","doi-asserted-by":"publisher","DOI":"10.1093\/narcan\/zcad005","volume":"5","author":"J Anand","year":"2023","unstructured":"Anand, J. et al. Roles of trans-lesion synthesis (TLS) DNA polymerases in tumorigenesis and cancer therapy. NAR Cancer 5, zcad005 (2023).","journal-title":"NAR Cancer"},{"key":"2940_CR355","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/s41568-018-0020-9","volume":"18","author":"S Joshi","year":"2018","unstructured":"Joshi, S. et al. Adapting to stress - chaperome networks in cancer. Nat. Rev. Cancer 18, 562\u2013575 (2018).","journal-title":"Nat. Rev. Cancer"},{"key":"2940_CR356","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-025-02472-x","volume":"24","author":"C Zhang","year":"2025","unstructured":"Zhang, C., Li, J., Tang, Q., Li, L. & Cao, D. Targeting proteostasis for cancer therapy: current advances, challenges, and future perspectives. Mol. Cancer 24, 265 (2025).","journal-title":"Mol. Cancer"},{"key":"2940_CR357","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41568-020-00312-2","volume":"21","author":"X Chen","year":"2021","unstructured":"Chen, X. & Cubillos-Ruiz, J. R. Endoplasmic reticulum stress signals in the tumour and its microenvironment. Nat. Rev. Cancer 21, 71\u201388 (2021).","journal-title":"Nat. Rev. Cancer"},{"key":"2940_CR358","doi-asserted-by":"publisher","first-page":"3881","DOI":"10.1038\/onc.2010.153","volume":"29","author":"E Bobrovnikova-Marjon","year":"2010","unstructured":"Bobrovnikova-Marjon, E. et al. PERK promotes cancer cell proliferation and tumor growth by limiting oxidative DNA damage. Oncogene 29, 3881\u20133895 (2010).","journal-title":"Oncogene"},{"key":"2940_CR359","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1016\/j.cell.2015.05.025","volume":"161","author":"JR Cubillos-Ruiz","year":"2015","unstructured":"Cubillos-Ruiz, J. R. et al. ER stress sensor XBP1 controls anti-tumor immunity by disrupting dendritic cell homeostasis. Cell 161, 1527\u20131538 (2015).","journal-title":"Cell"},{"key":"2940_CR360","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-023-01438-0","volume":"22","author":"J He","year":"2024","unstructured":"He, J., Zhou, Y. & Sun, L. Emerging mechanisms of the unfolded protein response in therapeutic resistance: from chemotherapy to Immunotherapy. Cell Commun. Signal. 22, 89 (2024).","journal-title":"Cell Commun. Signal."},{"key":"2940_CR361","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.ccell.2023.01.009","volume":"41","author":"EN Arner","year":"2023","unstructured":"Arner, E. N. & Rathmell, J. C. Metabolic programming and immune suppression in the tumor microenvironment. Cancer Cell 41, 421\u2013433 (2023).","journal-title":"Cancer Cell"},{"key":"2940_CR362","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1016\/j.semcancer.2022.10.001","volume":"86","author":"R Kant","year":"2022","unstructured":"Kant, R. et al. Deregulated transcription factors in cancer cell metabolisms and reprogramming. Semin. Cancer Biol. 86, 1158\u20131174 (2022).","journal-title":"Semin. Cancer Biol."},{"key":"2940_CR363","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.coi.2017.04.003","volume":"46","author":"PC Ho","year":"2017","unstructured":"Ho, P. C. & Kaech, S. M. Reenergizing T cell anti-tumor immunity by harnessing immunometabolic checkpoints and machineries. Curr. Opin. Immunol. 46, 38\u201344 (2017).","journal-title":"Curr. Opin. Immunol."},{"key":"2940_CR364","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1038\/s41588-025-02204-3","volume":"57","author":"K Zhao","year":"2025","unstructured":"Zhao, K. al. Longitudinal and multisite sampling reveals mutational and copy number evolution in tumors during metastatic dissemination. Nat. Genet. 57, 1504\u20131511 (2025).","journal-title":"Nat. Genet."},{"key":"2940_CR365","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/42701","volume":"387","author":"P Sniegowski","year":"1997","unstructured":"Sniegowski, P., Gerrish, P. & Lenski, R. Evolution of high mutation rates in experimental populations of E. coli. Nature 387, 703\u2013705 (1997).","journal-title":"Nature"},{"key":"2940_CR366","doi-asserted-by":"publisher","first-page":"E2498","DOI":"10.1073\/pnas.1601208113","volume":"113","author":"H Long","year":"2016","unstructured":"Long, H. et al. Antibiotic treatment enhances the genome-wide mutation rate of target cells. Proc. Natl. Acad. Sci. USA 113, E2498\u2013E2505 (2016).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2940_CR367","doi-asserted-by":"publisher","first-page":"e1002251","DOI":"10.1371\/journal.pbio.1002251","volume":"13","author":"JM Cuevas","year":"2015","unstructured":"Cuevas, J. M., Geller, R., Garijo, R., L\u00f3pez-Aldeguer, J. & Sanju\u00e1n, R. Extremely high mutation rate of HIV-1 in vivo. PLoS Biol. 13, e1002251 (2015).","journal-title":"PLoS Biol."},{"key":"2940_CR368","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1126\/science.aaa6806","volume":"348","author":"I Martincorena","year":"2015","unstructured":"Martincorena, I. et al. Tumor evolution. High burden and pervasive positive selection of somatic mutations in normal human skin. Science 348, 880\u2013886 (2015).","journal-title":"Science"},{"key":"2940_CR369","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1126\/science.959840","volume":"194","author":"PC Nowell","year":"1976","unstructured":"Nowell, P. C. The clonal evolution of tumor cell populations. Science 194, 23\u201328 (1976).","journal-title":"Science"},{"key":"2940_CR370","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/nature07943","volume":"458","author":"MR Stratton","year":"2009","unstructured":"Stratton, M. R., Campbell, P. J. & Futreal, P. A. The cancer genome. Nature 458, 719\u2013724 (2009).","journal-title":"Nature"},{"key":"2940_CR371","doi-asserted-by":"publisher","first-page":"e108389","DOI":"10.15252\/embj.2021108389","volume":"40","author":"R Vendramin","year":"2021","unstructured":"Vendramin, R., Litchfield, K. & Swanton, C. Cancer evolution: Darwin and beyond. EMBO J. 40, e108389 (2021).","journal-title":"EMBO J."},{"key":"2940_CR372","doi-asserted-by":"publisher","first-page":"4875","DOI":"10.1158\/0008-5472.CAN-12-2217","volume":"72","author":"C Swanton","year":"2012","unstructured":"Swanton, C. Intratumor heterogeneity: evolution through space and time. Cancer Res. 72, 4875\u20134882 (2012).","journal-title":"Cancer Res."},{"key":"2940_CR373","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/ng.3214","volume":"47","author":"A Sottoriva","year":"2015","unstructured":"Sottoriva, A. et al. A Big Bang model of human colorectal tumor growth. Nat. Genet. 47, 209\u2013216 (2015).","journal-title":"Nat. Genet."},{"key":"2940_CR374","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1002\/path.4757","volume":"240","author":"WCH Cross","year":"2016","unstructured":"Cross, W. C. H. et al. New paradigms in clonal evolution: punctuated equilibrium in cancer. J. Pathol. 240, 126\u2013136 (2016).","journal-title":"J. Pathol."},{"key":"2940_CR375","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cell.2010.11.055","volume":"144","author":"PJ Stephens","year":"2011","unstructured":"Stephens, P. J. et al. Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell 144, 27\u201340 (2011).","journal-title":"Cell"},{"key":"2940_CR376","unstructured":"ICGC\/TCGA pan-cancer analysis of whole genomes Consortium. Pan-cancer analysis of whole genomes. Nature 578, 82\u201393 (2020)."},{"key":"2940_CR377","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/nrm2718","volume":"10","author":"AJ Holland","year":"2009","unstructured":"Holland, A. J. & Cleveland, D. W. Boveri revisited: chromosomal instability, aneuploidy and tumorigenesis. Nat. Rev. Mol. Cell Biol. 10, 478\u2013487 (2009).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2940_CR378","doi-asserted-by":"publisher","first-page":"M57","DOI":"10.1016\/S0962-8924(99)01661-X","volume":"9","author":"DP Cahill","year":"1999","unstructured":"Cahill, D. P., Kinzler, K. W., Vogelstein, B. & Lengauer, C. Genetic instability and Darwinian selection in tumours. Trends Cell Biol. 9, M57\u2013M60 (1999).","journal-title":"Trends Cell Biol."},{"key":"2940_CR379","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1126\/science.1160058","volume":"322","author":"BR Williams","year":"2008","unstructured":"Williams, B. R. et al. Aneuploidy affects proliferation and spontaneous immortalization in mammalian cells. Science 322, 703\u2013709 (2008).","journal-title":"Science"},{"key":"2940_CR380","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/ijc.31718","volume":"144","author":"G Simonetti","year":"2019","unstructured":"Simonetti, G., Bruno, S., Padella, A., Tenti, E. & Martinelli, G. Aneuploidy: cancer strength or vulnerability? Int. J. Cancer 144, 8\u201325 (2019).","journal-title":"Int. J. Cancer"},{"key":"2940_CR381","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/s41576-020-00299-4","volume":"22","author":"E Persi","year":"2021","unstructured":"Persi, E. et al. Mutation\u2013selection balance and compensatory mechanisms in tumour evolution. Nat. Rev. Genet. 22, 251\u2013262 (2021).","journal-title":"Nat. Rev. Genet."},{"key":"2940_CR382","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15279-9","volume":"11","author":"WHM Hoevenaar","year":"2020","unstructured":"Hoevenaar, W. H. M. et al. Degree and site of chromosomal instability define its oncogenic potential. Nat. Commun. 11, 1501 (2020).","journal-title":"Nat. Commun."},{"key":"2940_CR383","doi-asserted-by":"publisher","first-page":"8995","DOI":"10.1073\/pnas.0700631104","volume":"104","author":"C Gao","year":"2007","unstructured":"Gao, C. et al. Chromosome instability, chromosome transcriptome, and clonal evolution of tumor cell populations. Proc. Natl. Acad. Sci. USA 104, 8995\u20139000 (2007).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2940_CR384","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1101\/gad.348319.121","volume":"35","author":"O Shoshani","year":"2021","unstructured":"Shoshani, O. et al. Transient genomic instability drives tumorigenesis through accelerated clonal evolution. Genes Dev. 35, 1093\u20131108 (2021).","journal-title":"Genes Dev."},{"key":"2940_CR385","doi-asserted-by":"publisher","first-page":"7017","DOI":"10.1073\/pnas.0401943101","volume":"101","author":"NL Komarova","year":"2004","unstructured":"Komarova, N. L. & Wodarz, D. The optimal rate of chromosome loss for the inactivation of tumor suppressor genes in cancer. Proc. Natl. Acad. Sci. USA 101, 7017\u20137021 (2004).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2940_CR386","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1158\/1055-9965.EPI-11-0343","volume":"20","author":"R Roylance","year":"2011","unstructured":"Roylance, R. et al. Relationship of extreme chromosomal instability with long-term survival in a retrospective analysis of primary breast cancer. Cancer Epidemiol. Biomark. Prev. 20, 2183\u20132194 (2011).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"2940_CR387","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1093\/annonc\/mdv178","volume":"26","author":"M Jamal-Hanjani","year":"2015","unstructured":"Jamal-Hanjani, M. et al. Extreme chromosomal instability forecasts improved outcome in ER-negative breast cancer: a prospective validation cohort study from the TACT trial. Ann. Oncol. 26, 1340\u20131346 (2015).","journal-title":"Ann. Oncol."},{"key":"2940_CR388","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/0027-5107(64)90047-8","volume":"106","author":"HJ Muller","year":"1964","unstructured":"Muller, H. J. The relation of recombination to mutational advance. Mutat. Res. 106, 2\u20139 (1964).","journal-title":"Mutat. Res."},{"key":"2940_CR389","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/nrclinonc.2017.198","volume":"15","author":"L Sansregret","year":"2018","unstructured":"Sansregret, L., Vanhaesebroeck, B. & Swanton, C. Determinants and clinical implications of chromosomal instability in cancer. Nat. Rev. Clin. Oncol. 15, 139\u2013150 (2018).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"2940_CR390","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1002\/bies.201400218","volume":"37","author":"B Bakker","year":"2015","unstructured":"Bakker, B., van den Bos, H., Lansdorp, P. M. & Foijer, F. How to count chromosomes in a cell: An overview of current and novel technologies. Bioessays 37, 570\u2013577 (2015).","journal-title":"Bioessays"},{"key":"2940_CR391","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1038\/s41379-022-01080-0","volume":"35","author":"A Lashen","year":"2022","unstructured":"Lashen, A. et al. The characteristics and clinical significance of atypical mitosis in breast cancer. Mod. Pathol. 35, 1341\u20131348 (2022).","journal-title":"Mod. Pathol."},{"key":"2940_CR392","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1038\/ng1861","volume":"38","author":"SL Carter","year":"2006","unstructured":"Carter, S. L., Eklund, A. C., Kohane, I. S., Harris, L. N. & Szallasi, Z. A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers. Nat. Genet. 38, 1043\u20131048 (2006).","journal-title":"Nat. Genet."},{"key":"2940_CR393","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nrc.2017.58","volume":"17","author":"T Baslan","year":"2017","unstructured":"Baslan, T. & Hicks, J. Unravelling biology and shifting paradigms in cancer with single-cell sequencing. Nat. Rev. Cancer 17, 557\u2013569 (2017).","journal-title":"Nat. Rev. Cancer"},{"key":"2940_CR394","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2309621121","volume":"121","author":"AR Lynch","year":"2024","unstructured":"Lynch, A. R. et al. A survey of chromosomal instability measures across mechanistic models. Proc. Natl. Acad. Sci. USA 121, e2309621121 (2024).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2940_CR395","doi-asserted-by":"publisher","first-page":"101658","DOI":"10.1016\/j.gim.2025.101658","volume":"28","author":"KM Schieffer","year":"2026","unstructured":"Schieffer, K. M. et al. Points to consider for the next-generation-sequencing-based detection of copy-number abnormalities (CNAs) and balanced chromosomal rearrangements in neoplastic disorders: A statement of the American College of Medical Genetics and Genomics (ACMG). Genet. Med. 28, 101658 (2026).","journal-title":"Genet. Med."},{"key":"2940_CR396","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/s41586-025-09632-5","volume":"648","author":"MR Cosenza","year":"2025","unstructured":"Cosenza, M. R. et al. Origins of chromosome instability unveiled by coupled imaging and genomics. Nature 648, 383\u2013393 (2025).","journal-title":"Nature"},{"key":"2940_CR397","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1016\/j.cell.2023.03.029","volume":"186","author":"N Bosco","year":"2023","unstructured":"Bosco, N. et al. KaryoCreate: a CRISPR-based technology to study chromosome-specific aneuploidy by targeting human centromeres. Cell 186, 1985\u20132001.e19 (2023).","journal-title":"Cell"},{"key":"2940_CR398","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.101579","volume":"13","author":"L DiPeso","year":"2025","unstructured":"DiPeso, L. et al. Image-based identification and isolation of micronucleated cells to dissect cellular consequences. Elife 13, RP101579 (2025).","journal-title":"Elife"},{"key":"2940_CR399","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42651-2","volume":"14","author":"DD Erdmann-Pham","year":"2023","unstructured":"Erdmann-Pham, D. D. et al. Tracing cancer evolution and heterogeneity using Hi-C. Nat. Commun. 14, 7111 (2023).","journal-title":"Nat. Commun."},{"key":"2940_CR400","first-page":"e2412232","volume":"12","author":"MA Dautle","year":"2025","unstructured":"Dautle, M. A. & Chen, Y. Single-cell Hi-C technologies and computational data analysis. Adv. Sci. (Weinh.) 12, e2412232 (2025).","journal-title":"Adv. Sci. (Weinh.)"},{"key":"2940_CR401","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/s41588-025-02468-9","volume":"58","author":"H Zhang","year":"2026","unstructured":"Zhang, H. et al. Genomic evolution of pancreatic cancer at single-cell resolution. Nat. Genet. 58, 355\u2013365 (2026).","journal-title":"Nat. Genet."},{"key":"2940_CR402","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/s43586-024-00330-6","volume":"4","author":"JL Carstens","year":"2024","unstructured":"Carstens, J. L. et al. Spatial multiplexing and omics. Nat. Rev. Methods Prim. 4, 54 (2024).","journal-title":"Nat. Rev. Methods Prim."},{"key":"2940_CR403","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1038\/s41587-021-00911-w","volume":"39","author":"CY Wu","year":"2021","unstructured":"Wu, C. Y. et al. Integrative single-cell analysis of allele-specific copy number alterations and chromatin accessibility in cancer. Nat. Biotechnol. 39, 1259\u20131269 (2021).","journal-title":"Nat. Biotechnol."},{"key":"2940_CR404","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36790-9","volume":"14","author":"A De Falco","year":"2023","unstructured":"De Falco, A., Caruso, F., Su, X. D., Iavarone, A. & Ceccarelli, M. A variational algorithm to detect the clonal copy number substructure of tumors from scRNA-seq data. Nat. Commun. 14, 1074 (2023).","journal-title":"Nat. Commun."},{"key":"2940_CR405","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/s41392-025-02538-8","volume":"11","author":"H Duan","year":"2026","unstructured":"Duan, H. et al. Micronuclei: origins, assays, mechanisms, diseases and treatments. Sig. Transduct. Target. Ther. 11, 114 (2026).","journal-title":"Sig. Transduct. Target. Ther."},{"key":"2940_CR406","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/j.cell.2018.08.039","volume":"174","author":"L Keren","year":"2018","unstructured":"Keren, L. et al. A structured tumor-immune microenvironment in triple negative breast cancer revealed by multiplexed ion beam imaging. Cell 174, 1373\u20131387.e19 (2018).","journal-title":"Cell"},{"key":"2940_CR407","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ccell.2025.12.009","volume":"44","author":"Y Liu","year":"2026","unstructured":"Liu, Y., Dai, Y. & Wang, L. Spatial omics at the forefront: emerging technologies, analytical innovations, and clinical applications. Cancer Cell 44, 24\u201349 (2026).","journal-title":"Cancer Cell"},{"key":"2940_CR408","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s10238-025-01965-9","volume":"26","author":"CY Hsu","year":"2025","unstructured":"Hsu, C. Y. et al. AI-driven multi-omics integration in precision oncology: bridging the data deluge to clinical decisions. Clin. Exp. Med. 26, 29 (2025).","journal-title":"Clin. Exp. Med."},{"key":"2940_CR409","doi-asserted-by":"publisher","first-page":"5050","DOI":"10.1016\/j.bmc.2014.02.035","volume":"22","author":"JJ Field","year":"2014","unstructured":"Field, J. J., Kanakkanthara, A. & Miller, J. H. Microtubule-targeting agents are clinically successful due to both mitotic and interphase impairment of microtubule function. Bioorg. Med. Chem. 22, 5050\u20135059 (2014).","journal-title":"Bioorg. Med. Chem."},{"key":"2940_CR410","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.molcel.2015.11.006","volume":"60","author":"C Dominguez-Brauer","year":"2015","unstructured":"Dominguez-Brauer, C. et al. Targeting mitosis in cancer: emerging strategies. Mol. Cell 60, 524\u2013536 (2015).","journal-title":"Mol. Cell"},{"key":"2940_CR411","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41568-022-00535-5","volume":"23","author":"FJ Groelly","year":"2023","unstructured":"Groelly, F. J., Fawkes, M., Dagg, R. A., Blackford, A. N. & Tarsounas, M. Targeting DNA damage response pathways in cancer. Nat. Rev. Cancer 23, 78\u201394 (2023).","journal-title":"Nat. Rev. Cancer"},{"key":"2940_CR412","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1002\/cncr.11578","volume":"98","author":"D Cella","year":"2003","unstructured":"Cella, D., Peterman, A., Hudgens, S., Webster, K. & Socinski, M. A. Measuring the side effects of taxane therapy in oncology: the functional assesment of cancer therapy-taxane (FACT-taxane). Cancer 98, 822\u2013831 (2003).","journal-title":"Cancer"},{"key":"2940_CR413","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.molcel.2015.10.040","volume":"60","author":"MJ O\u2019Connor","year":"2015","unstructured":"O\u2019Connor, M. J. Targeting the DNA damage response in cancer. Mol. Cell 60, 547\u2013560 (2015).","journal-title":"Mol. Cell"},{"key":"2940_CR414","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s10555-009-9185-8","volume":"28","author":"D Huszar","year":"2009","unstructured":"Huszar, D., Theoclitou, M. E., Skolnik, J. & Herbst, R. Kinesin motor proteins as targets for cancer therapy. Cancer Metastasis Rev. 28, 197\u2013208 (2009).","journal-title":"Cancer Metastasis Rev."},{"key":"2940_CR415","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/nrd4360","volume":"13","author":"KJ Falkenberg","year":"2014","unstructured":"Falkenberg, K. J. & Johnstone, R. W. Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders. Nat. Rev. Drug Discov. 13, 673\u2013691 (2014).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2940_CR416","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41573-021-00339-6","volume":"21","author":"ZE Stine","year":"2022","unstructured":"Stine, Z. E., Schug, Z. T., Salvino, J. M. & Dang, C. V. Targeting cancer metabolism in the era of precision oncology. Nat. Rev. Drug Discov. 21, 141\u2013162 (2022).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2940_CR417","doi-asserted-by":"publisher","first-page":"4145","DOI":"10.1007\/s12013-025-01821-3","volume":"83","author":"AN Joof","year":"2025","unstructured":"Joof, A. N., Bajinka, O., Zhou, Y., Ren, F. & Tan, Y. The central role of NRF2 in cancer metabolism and redox signaling: novel insights into crosstalk with ER stress and therapeutic modulation. Cell. Biochem. Biophys. 83, 4145\u20134161 (2025).","journal-title":"Cell. Biochem. Biophys."},{"key":"2940_CR418","doi-asserted-by":"publisher","first-page":"101223","DOI":"10.1016\/j.drup.2025.101223","volume":"81","author":"GL Beretta","year":"2025","unstructured":"Beretta, G. L. et al. Novel insights into taxane pharmacology: an update on drug resistance mechanisms, immunomodulation and drug delivery strategies. Drug Resist. Update 81, 101223 (2025).","journal-title":"Drug Resist. Update"},{"key":"2940_CR419","doi-asserted-by":"publisher","first-page":"1127623","DOI":"10.3389\/fimmu.2023.1127623","volume":"14","author":"AF Serpico","year":"2023","unstructured":"Serpico, A. F., Pisauro, C. & Grieco, D. cGAS-dependent proinflammatory and immune homeostatic effects of the microtubule-targeting agent paclitaxel. Front. Immunol. 14, 1127623 (2023).","journal-title":"Front. Immunol."},{"key":"2940_CR420","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2567-0","volume":"11","author":"AF Serpico","year":"2020","unstructured":"Serpico, A. F., Visconti, R. & Grieco, D. Exploiting immune-dependent effects of microtubule-targeting agents to improve efficacy and tolerability of cancer treatment. Cell Death Dis. 11, 361 (2020).","journal-title":"Cell Death Dis."},{"key":"2940_CR421","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1038\/nrd3253","volume":"9","author":"C Dumontet","year":"2010","unstructured":"Dumontet, C. & Jordan, M. A. Microtubule-binding agents: a dynamic field of cancer therapeutics. Nat. Rev. Drug Discov. 9, 780\u2013803 (2010).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2940_CR422","doi-asserted-by":"publisher","first-page":"10255","DOI":"10.1158\/0008-5472.CAN-10-2101","volume":"70","author":"R Colombo","year":"2010","unstructured":"Colombo, R. et al. Targeting the mitotic checkpoint for cancer therapy with NMS-P715, an inhibitor of MPS1 kinase. Cancer Res. 70, 10255\u201310264 (2010).","journal-title":"Cancer Res."},{"key":"2940_CR423","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/s41586-020-03114-6","volume":"590","author":"Y Cohen-Sharir","year":"2021","unstructured":"Cohen-Sharir, Y. et al. Aneuploidy renders cancer cells vulnerable to mitotic checkpoint inhibition. Nature 590, 486\u2013491 (2021).","journal-title":"Nature"},{"key":"2940_CR424","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1038\/s41416-018-0081-2","volume":"118","author":"ARR Maia","year":"2018","unstructured":"Maia, A. R. R. et al. Mps1 inhibitors synergise with low doses of taxanes in promoting tumour cell death by enhancement of errors in cell division. Br. J. Cancer 118, 1586\u20131595 (2018).","journal-title":"Br. J. Cancer"},{"key":"2940_CR425","doi-asserted-by":"publisher","first-page":"116504","DOI":"10.1016\/j.ejmech.2024.116504","volume":"273","author":"C Liang","year":"2024","unstructured":"Liang, C. et al. Hijacking monopolar spindle 1 (MPS1) for various cancer types by small molecular inhibitors: deep insights from a decade of research and patents. Eur. J. Med. Chem. 273, 116504 (2024).","journal-title":"Eur. J. Med. Chem."},{"key":"2940_CR426","doi-asserted-by":"publisher","first-page":"E1570","DOI":"10.1073\/pnas.1719577115","volume":"115","author":"KL Thu","year":"2018","unstructured":"Thu, K. L. et al. Disruption of the anaphase-promoting complex confers resistance to TTK inhibitors in triple-negative breast cancer. Proc. Natl. Acad. Sci. USA 115, E1570\u2013E1577 (2018).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2940_CR427","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1007\/s10637-015-0211-0","volume":"33","author":"PM LoRusso","year":"2015","unstructured":"LoRusso, P. M. et al. First-in-human phase 1 study of filanesib (ARRY-520), a kinesin spindle protein inhibitor, in patients with advanced solid tumors. Investig. N. Drugs 33, 440\u2013449 (2015).","journal-title":"Investig. N. Drugs"},{"key":"2940_CR428","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s00280-011-1756-z","volume":"69","author":"V Chung","year":"2012","unstructured":"Chung, V. et al. First-time-in-human study of GSK923295, a novel antimitotic inhibitor of centromere-associated protein E (CENP-E), in patients with refractory cancer. Cancer Chemother. Pharmacol. 69, 733\u2013741 (2012).","journal-title":"Cancer Chemother. Pharmacol."},{"key":"2940_CR429","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.cub.2009.12.049","volume":"20","author":"Y Du","year":"2010","unstructured":"Du, Y., English, C. A. & Ohi, R. The kinesin-8 Kif18A dampens microtubule plus-end dynamics. Curr. Biol. 20, 374\u2013380 (2010).","journal-title":"Curr. Biol."},{"key":"2940_CR430","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.devcel.2007.11.014","volume":"14","author":"J Stumpff","year":"2008","unstructured":"Stumpff, J., von Dassow, G., Wagenbach, M., Asbury, C. & Wordeman, L. The kinesin-8 motor Kif18A suppresses kinetochore movements to control mitotic chromosome alignment. Dev. Cell. 14, 252\u2013262 (2008).","journal-title":"Dev. Cell."},{"key":"2940_CR431","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.1016\/j.cub.2018.06.026","volume":"28","author":"LME Janssen","year":"2018","unstructured":"Janssen, L. M. E. et al. Loss of Kif18A results in spindle assembly checkpoint activation at microtubule-attached kinetochores. Curr. Biol. 28, 2685\u20132696 (2018).","journal-title":"Curr. Biol."},{"key":"2940_CR432","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/s44318-024-00031-6","volume":"43","author":"CR Gliech","year":"2024","unstructured":"Gliech, C. R. et al. Weakened APC\/C activity at mitotic exit drives cancer vulnerability to KIF18A inhibition. EMBO J. 43, 666\u2013694 (2024).","journal-title":"EMBO J."},{"key":"2940_CR433","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/s43018-023-00699-5","volume":"5","author":"M Payton","year":"2024","unstructured":"Payton, M. et al. Small-molecule inhibition of kinesin KIF18A reveals a mitotic vulnerability enriched in chromosomally unstable cancers. Nat. Cancer 5, 66\u201384 (2024).","journal-title":"Nat. Cancer"},{"key":"2940_CR434","doi-asserted-by":"publisher","first-page":"LB202","DOI":"10.1158\/1538-7445.AM2022-LB202","volume":"82","author":"J Sun","year":"2022","unstructured":"Sun, J. et al. Discovery and preclinical characterization of novel small molecule inhibitors of kinesin KIF18A motor protein with potent activity against chromosomally unstable cancers. Cancer Res. 82, LB202 (2022).","journal-title":"Cancer Res."},{"key":"2940_CR435","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1158\/1538-7445.AM2023-516","volume":"83","author":"B Belmontes","year":"2023","unstructured":"Belmontes, B. et al. Discovery and preclinical characterization of AMG 650, a first-in-class inhibitor of kinesin KIF18A motor protein with potent activity against chromosomally unstable cancers. Cancer Res. 83, 516 (2023).","journal-title":"Cancer Res."},{"key":"2940_CR436","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1158\/1538-7445.AM2025-1482","volume":"85","author":"Q Li","year":"2025","unstructured":"Li, Q. et al. Discovery of HW221043, a potent and orally bioavailable KIF18A inhibitor for treating chromosomal instability in cancer. Cancer Res. 85, 1482 (2025).","journal-title":"Cancer Res."},{"key":"2940_CR437","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s13045-020-00959-2","volume":"13","author":"A Ghelli Luserna di Ror\u00e0","year":"2020","unstructured":"Ghelli Luserna di Ror\u00e0, A., Cerchione, C., Martinelli, G. & Simonetti, G. A WEE1 family business: regulation of mitosis, cancer progression, and therapeutic target. J. Hematol. Oncol. 13, 126 (2020).","journal-title":"J. Hematol. Oncol."},{"key":"2940_CR438","doi-asserted-by":"publisher","first-page":"110261","DOI":"10.1016\/j.celrep.2021.110261","volume":"38","author":"CR Elb\u00e6k","year":"2022","unstructured":"Elb\u00e6k, C. R. et al. WEE1 kinase protects the stability of stalled DNA replication forks by limiting CDK2 activity. Cell Rep. 38, 110261 (2022).","journal-title":"Cell Rep."},{"key":"2940_CR439","doi-asserted-by":"publisher","first-page":"23891","DOI":"10.1073\/pnas.1915108116","volume":"116","author":"TN Moiseeva","year":"2019","unstructured":"Moiseeva, T. N., Qian, C., Sugitani, N., Osmanbeyoglu, H. U. & Bakkenist, C. J. WEE1 kinase inhibitor AZD1775 induces CDK1 kinase-dependent origin firing in unperturbed G1- and S-phase cells. Proc. Natl. Acad. Sci. USA 116, 23891\u201323893 (2019).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2940_CR440","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s13046-016-0433-9","volume":"35","author":"R Visconti","year":"2016","unstructured":"Visconti, R., Della Monica, R. & Grieco, D. Cell cycle checkpoint in cancer: a therapeutically targetable double-edged sword. J. Exp. Clin. Cancer Res. 35, 153 (2016).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"2940_CR441","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms1886","volume":"3","author":"R Visconti","year":"2012","unstructured":"Visconti, R., Palazzo, L., Della Monica, R. & Grieco, D. Fcp1-dependent dephosphorylation is required for M-phase-promoting factor inactivation at mitosis exit. Nat. Commun. 3, 894 (2012).","journal-title":"Nat. Commun."},{"key":"2940_CR442","doi-asserted-by":"publisher","first-page":"110305","DOI":"10.1016\/j.celrep.2022.110305","volume":"38","author":"AF Serpico","year":"2022","unstructured":"Serpico, A. F., Febbraro, F., Pisauro, C. & Grieco, D. Compartmentalized control of Cdk1 drives mitotic spindle assembly. Cell Rep. 38, 110305 (2022).","journal-title":"Cell Rep."},{"key":"2940_CR443","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.tips.2016.06.006","volume":"37","author":"CJ Matheson","year":"2016","unstructured":"Matheson, C. J., Backos, D. S. & Reigan, P. Targeting WEE1 Kinase in Cancer. Trends Pharmacol. Sci. 37, 872\u2013881 (2016).","journal-title":"Trends Pharmacol. Sci."},{"key":"2940_CR444","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.1158\/1535-7163.MCT-13-0424","volume":"12","author":"AA Van Linden","year":"2013","unstructured":"Van Linden, A. A. et al. Inhibition of Wee1 sensitizes cancer cells to antimetabolite chemotherapeutics in vitro and in vivo, independent of p53 functionality. Mol. Cancer Ther. 12, 2675\u20132684 (2013).","journal-title":"Mol. Cancer Ther."},{"key":"2940_CR445","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0140-6736(20)32554-X","volume":"397","author":"S Lheureux","year":"2021","unstructured":"Lheureux, S. et al. Adavosertib plus gemcitabine for platinum-resistant or platinum-refractory recurrent ovarian cancer: a double-blind, randomised, placebo-controlled, phase 2 trial. Lancet 397, 281\u2013292 (2021).","journal-title":"Lancet"},{"key":"2940_CR446","doi-asserted-by":"publisher","first-page":"104710","DOI":"10.1016\/j.critrevonc.2025.104710","volume":"211","author":"K Thangaretnam","year":"2025","unstructured":"Thangaretnam, K. et al. WEE1 inhibition in cancer therapy: mechanisms, synergies, preclinical insights, and clinical trials. Crit. Rev. Oncol. Hematol. 211, 104710 (2025).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"2940_CR447","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.canlet.2020.09.016","volume":"497","author":"F Neizer-Ashun","year":"2021","unstructured":"Neizer-Ashun, F. & Bhattacharya, R. Reality CHEK: understanding the biology and clinical potential of CHK1. Cancer Lett. 497, 202\u2013211 (2021).","journal-title":"Cancer Lett."},{"key":"2940_CR448","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1158\/1535-7163.MCT-14-1037","volume":"14","author":"C King","year":"2015","unstructured":"King, C. et al. LY2606368 causes replication catastrophe and antitumor effects through CHK1-dependent mechanisms. Mol. Cancer Ther. 14, 2004\u20132013 (2015).","journal-title":"Mol. Cancer Ther."},{"key":"2940_CR449","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.4161\/cc.20899","volume":"11","author":"L Carrassa","year":"2012","unstructured":"Carrassa, L. et al. Combined inhibition of Chk1 and Wee1: in vitro synergistic effect translates to tumor growth inhibition in vivo. Cell Cycle 11, 2507\u20132517 (2012).","journal-title":"Cell Cycle"},{"key":"2940_CR450","doi-asserted-by":"publisher","first-page":"6127","DOI":"10.1158\/1078-0432.CCR-19-0448","volume":"25","author":"K Parmar","year":"2019","unstructured":"Parmar, K. et al. The CHK1 inhibitor prexasertib exhibits monotherapy activity in high-grade serous ovarian cancer models and sensitizes to PARP inhibition. Clin. Cancer Res. 25, 6127\u20136140 (2019).","journal-title":"Clin. Cancer Res."},{"key":"2940_CR451","doi-asserted-by":"publisher","first-page":"7709","DOI":"10.3390\/ijms26167709","volume":"26","author":"M Kciuk","year":"2025","unstructured":"Kciuk, M., Gruszka, R., Aleksandrowicz, M., \u015aliwi\u0144ska, A. & Kontek, R. ATR-CHK1 axis inhibitors in gastric cancer treatment. Int. J. Mol. Sci. 26, 7709 (2025).","journal-title":"Int. J. Mol. Sci."},{"key":"2940_CR452","doi-asserted-by":"publisher","first-page":"120185","DOI":"10.1098\/rsob.120185","volume":"3","author":"H Hochegger","year":"2013","unstructured":"Hochegger, H., H\u00e9garat, N. & Pereira-Leal, J. B. Aurora at the pole and equator: overlapping functions of Aurora kinases in the mitotic spindle. Open Biol. 3, 120185 (2013).","journal-title":"Open Biol."},{"key":"2940_CR453","doi-asserted-by":"publisher","first-page":"278","DOI":"10.3389\/fonc.2015.00278","volume":"5","author":"V Bavetsias","year":"2015","unstructured":"Bavetsias, V. & Linardopoulos, S. Aurora kinase inhibitors: current status and outlook. Front. Oncol. 5, 278 (2015).","journal-title":"Front. Oncol."},{"key":"2940_CR454","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaw8412","volume":"11","author":"A Lin","year":"2019","unstructured":"Lin, A. et al. Off-target toxicity is a common mechanism of action of cancer drugs undergoing clinical trials. Sci. Transl. Med. 11, eaaw8412 (2019).","journal-title":"Sci. Transl. Med."},{"key":"2940_CR455","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-025-02353-3","volume":"24","author":"P Vats","year":"2025","unstructured":"Vats, P. et al. Aurora kinases signaling in cancer: from molecular perception to targeted therapies. Mol. Cancer 24, 180 (2025).","journal-title":"Mol. Cancer"},{"key":"2940_CR456","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1158\/0008-5472.CAN-20-1377","volume":"81","author":"L Gheghiani","year":"2021","unstructured":"Gheghiani, L. et al. PLK1 induces chromosomal instability and overrides cell-cycle checkpoints to drive tumorigenesis. Cancer Res. 81, 1293\u20131307 (2021).","journal-title":"Cancer Res."},{"key":"2940_CR457","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1158\/1535-7163.MCT-15-0897","volume":"15","author":"REA Gutteridge","year":"2016","unstructured":"Gutteridge, R. E. A., Ndiaye, M. A., Liu, X. & Ahmad, N. Plk1 inhibitors in cancer therapy: from laboratory to clinics. Mol. Cancer Ther. 15, 1427\u20131435 (2016).","journal-title":"Mol. Cancer Ther."},{"key":"2940_CR458","doi-asserted-by":"publisher","first-page":"1602752","DOI":"10.3389\/fimmu.2025.1602752","volume":"16","author":"W Wang","year":"2025","unstructured":"Wang, W. et al. PLK1 in cancer therapy: a comprehensive review of immunomodulatory mechanisms and therapeutic opportunities. Front. Immunol. 16, 1602752 (2025).","journal-title":"Front. Immunol."},{"key":"2940_CR459","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.canlet.2008.06.005","volume":"274","author":"G Eot-Houllier","year":"2009","unstructured":"Eot-Houllier, G., Fulcrand, G., Magnaghi-Jaulin, L. & Jaulin, C. Histone deacetylase inhibitors and genomic instability. Cancer Lett. 274, 169\u2013176 (2009).","journal-title":"Cancer Lett."},{"key":"2940_CR460","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13045-024-01551-8","volume":"17","author":"MQ Shi","year":"2024","unstructured":"Shi, M. Q. et al. Advances in targeting histone deacetylase for treatment of solid tumors. J. Hematol. Oncol. 17, 37 (2024).","journal-title":"J. Hematol. Oncol."},{"key":"2940_CR461","doi-asserted-by":"publisher","first-page":"3238","DOI":"10.3390\/ijms23063238","volume":"23","author":"JL Huang","year":"2022","unstructured":"Huang, J. L., Chang, Y. T., Hong, Z. Y. & Lin, C. S. Targeting DNA damage response and Immune checkpoint for anticancer therapy. Int. J. Mol. Sci. 23, 3238 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"2940_CR462","doi-asserted-by":"publisher","first-page":"103662","DOI":"10.1016\/j.drudis.2023.103662","volume":"28","author":"B Priya","year":"2023","unstructured":"Priya, B., Ravi, S. & Kirubakaran, S. Targeting ATM and ATR for cancer therapeutics: inhibitors in clinic. Drug Discov. Today 28, 103662 (2023).","journal-title":"Drug Discov. Today"},{"key":"2940_CR463","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s11523-025-01136-6","volume":"20","author":"EA Ampolini","year":"2025","unstructured":"Ampolini, E. A., Jimenez-Sainz, J. & Long, D. T. The development of ATM inhibitors in cancer therapy. Target. Oncol. 20, 281\u2013297 (2025).","journal-title":"Target. Oncol."},{"key":"2940_CR464","doi-asserted-by":"publisher","first-page":"102808","DOI":"10.1016\/j.ctrv.2024.102808","volume":"129","author":"J Lee","year":"2024","unstructured":"Lee, J. Targeting the ATM pathway in cancer: opportunities, challenges and personalized therapeutic strategies. Cancer Treat. Rev. 129, 102808 (2024).","journal-title":"Cancer Treat. Rev."},{"key":"2940_CR465","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1080\/21541264.2018.1553483","volume":"10","author":"RP Fisher","year":"2019","unstructured":"Fisher, R. P. Cdk7: a kinase at the core of transcription and in the crosshairs of cancer drug discovery. Transcription 10, 47\u201356 (2019).","journal-title":"Transcription"},{"key":"2940_CR466","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1038\/nsmb.2399","volume":"19","author":"S Larochelle","year":"2012","unstructured":"Larochelle, S. et al. Cyclin-dependent kinase control of the initiation-to-elongation switch of RNA polymerase II. Nat. Struct. Mol. Biol. 19, 1108\u20131115 (2012).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"2940_CR467","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s10555-020-09885-8","volume":"39","author":"GP Sava","year":"2020","unstructured":"Sava, G. P., Fan, H., Coombes, R. C., Buluwela, L. & Ali, S. CDK7 inhibitors as anticancer drugs. Cancer Metastasis Rev. 39, 805\u2013823 (2020).","journal-title":"Cancer Metastasis Rev."},{"key":"2940_CR468","doi-asserted-by":"publisher","first-page":"104834","DOI":"10.1016\/j.jbc.2023.104834","volume":"299","author":"KM Piemonte","year":"2023","unstructured":"Piemonte, K. M. et al. Disruption of CDK7 signaling leads to catastrophic chromosomal instability coupled with a loss of condensin-mediated chromatin compaction. J. Biol. Chem. 299, 104834 (2023).","journal-title":"J. Biol. Chem."},{"key":"2940_CR469","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1080\/13543776.2023.2195547","volume":"33","author":"M Kovalov\u00e1","year":"2023","unstructured":"Kovalov\u00e1, M. et al. A patent review of cyclin-dependent kinase 7 (CDK7) inhibitors (2018-2022). Expert Opin. Ther. Pat. 33, 67\u201387 (2023).","journal-title":"Expert Opin. Ther. Pat."},{"key":"2940_CR470","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41392-025-02439-w","volume":"10","author":"OF Kuzu","year":"2025","unstructured":"Kuzu, O. F., Granerud, L. J. T. & Saatcioglu, F. Navigating the landscape of protein folding and proteostasis: from molecular chaperones to therapeutic innovations. Sig Transduct. Target Ther. 10, 358 (2025).","journal-title":"Sig Transduct. Target Ther."},{"key":"2940_CR471","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25684-3","volume":"12","author":"J Lin","year":"2021","unstructured":"Lin, J. et al. Targeting the IRE1alpha\/XBP1s pathway suppresses CARM1-expressing ovarian cancer. Nat. Commun. 12, 5321 (2021).","journal-title":"Nat. Commun."},{"key":"2940_CR472","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.202111068","volume":"221","author":"O Guttman","year":"2022","unstructured":"Guttman, O. et al. Antigen-derived peptides engage the ER stress sensor IRE1alpha to curb dendritic cell cross-presentation. J. Cell Biol. 221, e202111068 (2022).","journal-title":"J. Cell Biol."},{"key":"2940_CR473","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/s41420-025-02672-w","volume":"11","author":"W Zhang","year":"2025","unstructured":"Zhang, W. et al. Nicotinamide phosphoribosyltransferase in NAD+metabolism: physiological and pathophysiological implications. Cell Death Discov. 11, 371 (2025).","journal-title":"Cell Death Discov."},{"key":"2940_CR474","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41392-025-02141-x","volume":"10","author":"H Liu","year":"2025","unstructured":"Liu, H. et al. Energy metabolism in health and diseases. Sig. Transduct. Target. Ther. 10, 69 (2025).","journal-title":"Sig. Transduct. Target. Ther."},{"key":"2940_CR475","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.3390\/pharmaceutics14122657","volume":"14","author":"T Khan","year":"2022","unstructured":"Khan, T. et al. Mitochondrial dysfunction: pathophysiology and mitochondria-targeted drug delivery approaches. Pharmaceutics 14, 2657 (2022).","journal-title":"Pharmaceutics"},{"key":"2940_CR476","doi-asserted-by":"publisher","first-page":"3677","DOI":"10.1016\/j.molcel.2021.08.015","volume":"81","author":"E Trefts","year":"2021","unstructured":"Trefts, E. & Shaw, R. J. AMPK: restoring metabolic homeostasis over space and time. Mol. Cell. 81, 3677\u20133690 (2021).","journal-title":"Mol. Cell."},{"key":"2940_CR477","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s43556-026-00427-2","volume":"7","author":"M Yu","year":"2026","unstructured":"Yu, M. et al. Metabolic reprogramming in cancer: dysregulation of glucose, lipid, and amino acid pathways and therapeutic opportunities. Mol. Biomed. 7, 25 (2026).","journal-title":"Mol. Biomed."},{"key":"2940_CR478","doi-asserted-by":"publisher","first-page":"1674163","DOI":"10.3389\/fimmu.2025.1674163","volume":"16","author":"Z Fu","year":"2025","unstructured":"Fu, Z. et al. Endoplasmic reticulum stress orchestrates tumor metabolism and immunity: new insights into immunometabolic therapeutics. Front. Immunol. 16, 1674163 (2025).","journal-title":"Front. Immunol."},{"key":"2940_CR479","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/s41416-023-02324-9","volume":"129","author":"S Tardito","year":"2023","unstructured":"Tardito, S. & MacKay, C. Rethinking our approach to cancer metabolism to deliver patient benefit. Br. J. Cancer 129, 406\u2013415 (2023).","journal-title":"Br. J. Cancer"},{"key":"2940_CR480","doi-asserted-by":"publisher","DOI":"10.1172\/JCI148550","volume":"132","author":"KM Lemberg","year":"2022","unstructured":"Lemberg, K. M., Gori, S. S., Tsukamoto, T., Rais, R. & Slusher, B. S. Clinical development of metabolic inhibitors for oncology. J. Clin. Investig. 132, e148550 (2022).","journal-title":"J. Clin. Investig."},{"key":"2940_CR481","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.celrep.2015.04.031","volume":"11","author":"L Corrales","year":"2015","unstructured":"Corrales, L. et al. Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity. Cell Rep. 11, 1018\u20131030 (2015).","journal-title":"Cell Rep."},{"key":"2940_CR482","doi-asserted-by":"publisher","first-page":"155976","DOI":"10.1016\/j.cyto.2022.155976","volume":"158","author":"W Li","year":"2022","unstructured":"Li, W. et al. Blockade of IL-6 inhibits tumor immune evasion and improves anti-PD-1 immunotherapy. Cytokine 158, 155976 (2022).","journal-title":"Cytokine"},{"key":"2940_CR483","doi-asserted-by":"publisher","first-page":"e2500296","DOI":"10.1002\/advs.202500296","volume":"12","author":"L Gehrcken","year":"2025","unstructured":"Gehrcken, L., Deben, C., Smits, E. & Van Audenaerde, J. R. M. STING agonists and how to reach their full potential in cancer immunotherapy. Adv. Sci. 12, e2500296 (2025).","journal-title":"Adv. Sci."},{"key":"2940_CR484","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-007530","volume":"11","author":"MF Soler","year":"2023","unstructured":"Soler, M. F., Abaurrea, A., Azcoaga, P., Araujo, A. M. & Caffarel, M. M. New perspectives in cancer immunotherapy: targeting IL-6 cytokine family. J. Immunother. Cancer 11, e007530 (2023).","journal-title":"J. Immunother. Cancer"},{"key":"2940_CR485","doi-asserted-by":"publisher","first-page":"100839","DOI":"10.1016\/j.mtbio.2023.100839","volume":"23","author":"C Huang","year":"2023","unstructured":"Huang, C. et al. Overcoming challenges in the delivery of STING agonists for cancer immunotherapy: a comprehensive review of strategies and future perspectives. Mater. Today Bio. 23, 100839 (2023).","journal-title":"Mater. Today Bio."},{"key":"2940_CR486","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/nrclinonc.2018.8","volume":"15","author":"DE Johnson","year":"2018","unstructured":"Johnson, D. E., O\u2019Keefe, R. A. & Grandis, J. R. Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer. Nat. Rev. Clin. Oncol. 15, 234\u2013248 (2018).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"2940_CR487","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202308131","volume":"11","author":"Y An","year":"2024","unstructured":"An, Y. et al. Tumor exosomal ENPP1 hydrolyzes cGAMP to inhibit cGAS-STING signaling. Adv. Sci. 11, e2308131 (2024).","journal-title":"Adv. Sci."},{"key":"2940_CR488","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1158\/1078-0432.CCR-22-1681","volume":"29","author":"B Ruiz-Fern\u00e1ndez de C\u00f3rdoba","year":"2023","unstructured":"Ruiz-Fern\u00e1ndez de C\u00f3rdoba, B., Mart\u00ednez-Monge, R. & Lecanda, F. ENPP1 Immunobiology as a therapeutic target. Clin. Cancer Res. 29, 2184\u20132193 (2023).","journal-title":"Clin. Cancer Res."},{"key":"2940_CR489","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41392-021-00484-9","volume":"6","author":"X Xiang","year":"2021","unstructured":"Xiang, X., Wang, J., Lu, D. & Xu, X. Targeting tumor-associated macrophages to synergize tumor immunotherapy. Signal Transduct. Target. Ther. 6, 75 (2021).","journal-title":"Signal Transduct. Target. Ther."},{"key":"2940_CR490","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3389\/fimmu.2020.00018","volume":"11","author":"W Zhang","year":"2020","unstructured":"Zhang, W. et al. Advances in anti-tumor treatments targeting the CD47\/SIRP\u03b1 axis. Front. Immunol. 11, 18 (2020).","journal-title":"Front. Immunol."},{"key":"2940_CR491","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.ccell.2017.10.005","volume":"32","author":"V Kumar","year":"2017","unstructured":"Kumar, V. et al. Cancer-associated fibroblasts neutralize the anti-tumor effect of CSF1 receptor blockade by inducing PMN-MDSC infiltration of tumors. Cancer Cell 32, 654\u2013668.e5 (2017).","journal-title":"Cancer Cell"},{"key":"2940_CR492","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/s41571-024-00932-9","volume":"21","author":"J Budczies","year":"2024","unstructured":"Budczies, J. et al. Tumour mutational burden: clinical utility, challenges and emerging improvements. Nat. Rev. Clin. Oncol. 21, 725\u2013742 (2024).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"2940_CR493","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1158\/2159-8290.CD-20-1559","volume":"11","author":"C Bailey","year":"2021","unstructured":"Bailey, C. et al. Tracking cancer evolution through the disease course. Cancer Discov. 11, 916\u2013932 (2021).","journal-title":"Cancer Discov."},{"key":"2940_CR494","first-page":"1132","volume":"139","author":"A Goldberg","year":"2025","unstructured":"Goldberg, A., Trifas, M. & Davoli, T. Modeling and targeting general and chromosome-specific aneuploidy in cancer. Genes Dev. 139, 1132\u20131154 (2025).","journal-title":"Genes Dev."},{"key":"2940_CR495","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s10577-023-09724-w","volume":"31","author":"B Dhital","year":"2023","unstructured":"Dhital, B. & Rodriguez-Bravo, V. Mechanisms of chromosomal instability (CIN) tolerance in aggressive tumors: surviving the genomic chaos. Chromosome Res. 31, 15 (2023).","journal-title":"Chromosome Res."}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02940-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02940-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02940-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T17:02:32Z","timestamp":1789750952000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02940-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,18]]},"references-count":495,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2940"],"URL":"https:\/\/doi.org\/10.1038\/s41392-026-02940-w","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,18]]},"assertion":[{"value":"13 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"392"}}